Improving cardiometabolic and mental health in women with gestational diabetes mellitus and their offspring: study protocol for, a randomised controlled trial by Horsch, Antje et al.
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2018
Improving cardiometabolic and mental health in women with gestational
diabetes mellitus and their offspring: study protocol for, a randomised
controlled trial
Horsch, Antje; Gilbert, Leah; Lanzi, Stefano; Gross, Justine; Kayser, Bengt; Vial, Yvan; Simeoni,
Umberto; Hans, Didier; Berney, Alexandre; Scholz, Urte; Barakat, Ruben; Puder, Jardena J;
MySweetHeart, Research Group
Abstract: INTRODUCTION: Gestational diabetes mellitus (GDM) carries prenatal and perinatal risk
for the mother and her offspring as well as longer-term risks for both the mother (obesity, diabetes,
cardiovascular disease) and her child (obesity, type 2 diabetes). Compared with women without GDM,
women with GDM are twice as likely to develop perinatal or postpartum depression. Lifestyle interven-
tions for GDM are generally limited to physical activity and/or nutrition, often focus separately on the
mother or the child and take place either during or after pregnancy, while their results are inconsistent.
To increase efficacy of intervention, the multifactorial origins of GDM and the tight link between mental
and metabolic as well as maternal and child health need to be heeded. This calls for an interdisciplinary
transgenerational approach starting in, but continuing beyond pregnancy. METHODS AND ANALY-
SIS: This randomised controlled trial will assess the effect of a multidimensional interdisciplinary lifestyle
and psychosocial intervention aimed at improving the metabolic and mental health of 200 women with
GDM and their offspring. Women with GDM at 24-32 weeks gestational age who understand French or
English, and their offspring and partners can participate. The intervention components will be delivered
on top of usual care during pregnancy and the first year postpartum. Metabolic and mental health
outcomes will be measured at 24-32 weeks of pregnancy, shortly after birth and at 6-8 weeks and 1 year
after childbirth. Data will be analysed using intention-to-treat analyses. The is linked to the (clinicaltri-
als.gov/ct2/show/NCT02872974). ETHICS AND DISSEMINATION: We will disseminate the findings
through regional, national and international conferences and through peer-reviewed journals. TRIAL
REGISTRATION NUMBER: NCT02890693; Pre-results.
DOI: https://doi.org/10.1136/bmjopen-2017-020462
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: https://doi.org/10.5167/uzh-157091
Journal Article
Published Version
 
 
The following work is licensed under a Creative Commons: Attribution-NonCommercial 4.0 International
(CC BY-NC 4.0) License.
Originally published at:
Horsch, Antje; Gilbert, Leah; Lanzi, Stefano; Gross, Justine; Kayser, Bengt; Vial, Yvan; Simeoni, Um-
berto; Hans, Didier; Berney, Alexandre; Scholz, Urte; Barakat, Ruben; Puder, Jardena J; MySweetHeart,
Research Group (2018). Improving cardiometabolic and mental health in women with gestational diabetes
mellitus and their offspring: study protocol for, a randomised controlled trial. BMJ Open, 8(2):e020462.
DOI: https://doi.org/10.1136/bmjopen-2017-020462
2
1Horsch A, et al. BMJ Open 2018;8:e020462. doi:10.1136/bmjopen-2017-020462
Open Access 
Improving cardiometabolic and mental 
health in women with gestational 
diabetes mellitus and their offspring: 
study protocol for MySweetHeart Trial, 
a randomised controlled trial
Antje Horsch,1,2 Leah Gilbert,3 Stefano Lanzi,3,4 Justine Gross,3 Bengt Kayser,5 
Yvan Vial,1 Umberto Simeoni,6 Didier Hans,7 Alexandre Berney,8 Urte Scholz,9 
Ruben Barakat,10 Jardena J Puder,2,11 on behalf of MySweetHeart Research Group
To cite: Horsch A, Gilbert L, 
Lanzi S, et al.  Improving 
cardiometabolic and mental 
health in women with 
gestational diabetes mellitus 
and their offspring: study 
protocol for MySweetHeart 
Trial, a randomised 
controlled trial. BMJ Open 
2018;8:e020462. doi:10.1136/
bmjopen-2017-020462
 ► Prepublication history for 
this paper is available online. 
To view these files, please visit 
the journal online (http:// dx. doi. 
org/ 10. 1136/ bmjopen- 2017- 
020462). 
Received 6 November 2017
Accepted 10 November 2017
For numbered affiliations see 
end of article.
Correspondence to
Prof Antje Horsch;  
 antje. horsch@ chuv. ch
Protocol
AbstrACt
Introduction Gestational diabetes mellitus (GDM) carries 
prenatal and perinatal risk for the mother and her offspring 
as well as longer-term risks for both the mother (obesity, 
diabetes, cardiovascular disease) and her child (obesity, type 2 
diabetes). Compared with women without GDM, women with 
GDM are twice as likely to develop perinatal or postpartum 
depression. Lifestyle interventions for GDM are generally 
limited to physical activity and/or nutrition, often focus 
separately on the mother or the child and take place either 
during or after pregnancy, while their results are inconsistent. 
To increase efficacy of intervention, the multifactorial origins of 
GDM and the tight link between mental and metabolic as well 
as maternal and child health need to be heeded. This calls for 
an interdisciplinary transgenerational approach starting in, but 
continuing beyond pregnancy.
Methods and analysis This randomised controlled trial 
will assess the effect of a multidimensional interdisciplinary 
lifestyle and psychosocial intervention aimed at improving the 
metabolic and mental health of 200 women with GDM and 
their offspring. Women with GDM at 24–32 weeks gestational 
age who understand French or English, and their offspring and 
partners can participate. The intervention components will be 
delivered on top of usual care during pregnancy and the first 
year postpartum. Metabolic and mental health outcomes will 
be measured at 24–32 weeks of pregnancy, shortly after birth 
and at 6–8 weeks and 1 year after childbirth. Data will be 
analysed using intention-to-treat analyses. The MySweetHeart 
Trial is linked to the MySweetHeart Cohort ( clinicaltrials. gov/ 
ct2/ show/ NCT02872974).
Ethics and dissemination We will disseminate the 
findings through regional, national and international 
conferences and through peer-reviewed journals.
trial registration number NCT02890693; Pre-results.
IntroduCtIon
definition and prevalence of gestational diabetes 
mellitus (GdM)
GDM is characterised by glucose intolerance 
diagnosed during pregnancy not fulfilling the 
criteria for diabetes.1 2 It often resolves after 
childbirth,1 2 although up to 40% of women 
have prediabetes in the early postpartum 
period.3 In Switzerland, the prevalence of 
GDM is 10.8%.4 
Morbidity of GdM and related conditions
GDM carries prenatal and perinatal risk for 
the mother and her child and is also linked 
to postnatal risks. Long-term maternal risks 
include a 30%–70% GDM recurrence, a 
7-fold higher 5–10 year risk of type 2 diabetes 
and an increased risk of metabolic syndrome 
and cardiovascular disease.5–8 Compared with 
women without GDM, women with GDM are 
twice to four times9 as likely to develop ante-
natal or postpartum depression and approx-
imately one-third of women with recent 
GDM develop postpartum depression.10 
Postpartum depression leads to an increase 
in comfort eating and a decrease in physical 
strengths and limitations of this study
 ► The study will test the effects of a novel 
multidimensional interdisciplinary lifestyle 
and psychosocial intervention for women with 
gestational diabetes mellitus.
 ► The intervention focuses on both metabolic and 
mental health, of the mother and her offspring, 
which  starts during pregnancy and continues 
beyond birth.
 ► The intervention draws on theories of health 
behaviour change through motivational and 
systemic approaches.
 ► Methodological rigour, including concealment of 
random allocation, blinded outcome assessors, 
regular monitoring and prospective trial registration 
and publication, should limit risk of bias.
 ► Unblinded participants and clinicians for some of the 
secondary outcomes may increase the risk of bias.
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activity,11 thus putting the women at higher risk of weight 
gain and future diabetes.10
Regarding the child, the importance of the intrauterine 
and early postnatal environments for metabolic program-
ming and modifications of the epigenome is increasingly 
recognised,12–14 particularly for metabolic diseases such as 
obesity and diabetes.15 Thus, GDM is related to macro-
somia at birth (>4 kg), to excess body fat and (central) 
obesity and to insulin secretion in infants and children, 
the obesity being in part mediated by maternal body 
mass index (BMI) or birth weight.16–23 Intrauterine expo-
sure to GDM also doubles the risk for subsequent type 2 
diabetes in offspring compared with offspring of mothers 
with a high genetic predisposition for type 2 diabetes, but 
with normal glucose tolerance during the index preg-
nancy.24 Maternal prepregnancy overweight and excessive 
gestational weight gain also predict high birth weight and 
adiposity during infancy.12 25 This is highly relevant, as up 
to 60%–70% of women with GDM are overweight or obese 
before pregnancy.26 Finally, maternal lifestyle behaviour 
such as a high fat diet or lack of physical activity during 
pregnancy can influence offspring adiposity independent 
of maternal obesity.12 27
The higher risk for maternal postpartum depression is 
also associated with reduced parenting skills, which may 
have negative consequences for the development of the 
child.28–30 Parents of obese children may lack effective 
parenting skills providing both a consistent structured 
frame and emotional support.31 In women with GDM, 
psychosocial vulnerability including low levels of social 
and family networks is associated with more adverse 
neonatal outcomes, especially increased birth weight.32 
Thus, there is a tight interaction between maternal life-
style, weight status, mental health, social support as 
well as between maternal and child’s overall health. In 
view of the high worldwide prevalence of (childhood) 
obesity and associated metabolic problems, this close link 
between maternal and child metabolic health and the 
resulting vicious cycle are very relevant.33 34 Because of 
the deleterious impact of GDM and lifestyle during preg-
nancy on the health of the mother and her offspring, it 
is crucial to intervene during the prenatal, perinatal and 
postnatal period.
Modifiable risk factors of GdM
Risk factors for GDM that are modifiable during preg-
nancy include excessive weight gain which is a very 
frequent phenomenon that is observed in a majority 
of pregnant women (in up to 75% of pregnancies).35 36 
Further modifiable risk factors include lifestyle behaviours 
such as low levels of physical activity, high fat and animal 
protein consumption, high intake of added sugar and low 
intake of vegetable and fruit fiber.37 Regular food intake 
and avoidance of snacking can have beneficial effects on 
weight and glucose tolerance, but this has mostly been 
tested outside of pregnancy.38–42 Another key factor is 
mental health. Higher stress exposure and perceived 
stress during pregnancy have been linked to GDM and/or 
higher glucose levels in women.43–45 Psychological stress 
and negative life events can be associated with higher sali-
vary cortisol levels during pregnancy, which might relate 
to higher glucose levels.46 Higher depression scores early 
in pregnancy also increase the risk for GDM.9 47 On the 
other hand, social support has been shown to be protec-
tive regarding mental health and depression in partic-
ular.9 48 49
Physical activity, nutrition and depression are inter-
linked. Physical activity can reduce symptoms of depres-
sion,50 and there is a two-directional relationship between 
unhealthy eating and the incidence of symptoms of 
depression.51 Mindfulness and mindful eating can have 
a beneficial impact on weight loss and food cravings.52–54
Prior studies having evaluated lifestyle interventions in GdM
Most interventions in GDM focus either on dietary or on 
physical activity changes and only last during pregnancy.
 Dietary advice is recommended for all women with GDM 
to improve glycaemic control and to provide adequate 
nutrition.1 Of the few existing trials, the majority focused 
on either low carbohydrate or low glycaemic index foods. 
Results were not consistent and effect sizes were small, but 
low glycaemic diets, sometimes in combination of higher 
fibre intake, were found to have a favourable impact 
on insulin requirements, birth weight and/or maternal 
weight gain.55–57 A recent Cochrane review found that 
more evidence is needed to assess the effects of different 
types of dietary advice to give to women with GDM.58 
As fat, especially saturated fat, is a risk factor for both 
GDM and type 2 diabetes, decreasing animal fat intake 
represents an interesting novel approach.59–62 Indeed, 
a high-complex carbohydrate/low-fat diet improved 
glycaemic values and insulin resistance in women with 
GDM as well as infant adiposity in a pilot study of women 
with GDM.63 Regarding eating behaviour, a recent inter-
vention focusing on mindfulness-based eating awareness 
that aimed at increasing awareness of inner cues, such as 
hunger and satiety, at identification of emotional eating 
and eating triggers, had a beneficial impact on glycaemic 
control.64 65
Although recommended for GDM treatment, guide-
lines do not specify the type of physical activity or its 
timing in regards to meal intake.66 67 Aerobic and resis-
tance exercise can be accomplished during pregnancy 
in the absence of contraindications,68 but motivation, 
compliance, perceived health and lack of time appear to 
be major limiting factors.48 69 A recent review concluded 
that physical activity, both aerobic and resistance exer-
cise, may improve glycaemic control and/or limit insulin 
use in women with GDM.70 Regular physical activity can 
also limit pregnancy weight gain, stabilise maternal mood 
and reduce fetal fat mass (FM) and physiological stress 
responses in the offspring.27 69 71
To our knowledge, there are no evidence-based psycholog-
ical interventions for women with GDM and no international 
guidelines for psychosocial management exist,72 although 
evidence shows that inclusion of partners can be helpful.73 74
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Postpartum follow-up and interventions
Due to the increased risk of development or persistence 
of prediabetes and diabetes, management of women 
with GDM in the postpartum period is essential. The 
American Diabetes Association, the American College 
of Obstetricians and Gynaecologists and the National 
Diabetes Education Program recommend testing within 
4–12 weeks postpartum with a 2 hour 75 g oral glucose 
tolerance test (oGTT).2 75 76
Weightloss is an important predictor to prevent diabetes 
in this high-risk population. Thus, in the Diabetes Preven-
tion Program, weight loss after GDM reduced future 
diabetes incidence by 16% for every kilogram lost.77 The 
Nurses Health Study found that healthy diet patterns 
such as a Mediterranean diet, a Dietary approaches to 
stop hypertension (DASH) pattern diet or an Alterna-
tive Healthy Eating diet reduced diabetes incidence by 
40%–57% in women who had GDM 14 years before.78 
Evidence of the Gestational Diabetes’ Effects on Moms 
study shows that a lifestyle intervention that starts during 
pregnancy and continues postpartum is feasible and may 
prevent pregnancy weight retention and help overweight 
women lose weight.79 80
In the postpartum period after GDM, low social support 
was related to low adherence to a healthy lifestyle, thus 
contributing to an increased risk of type 2 diabetes.81 
In another study, social support was a key factor for the 
adoption of physical activity among women after GDM.82 
Finally, integrating partners into the intervention helped 
to maximise participation in an intervention that aimed 
to prevent type 2 diabetes after GDM.74
Prevention strategies for the child
Offspring of women with GDM are at higher risk for child-
hood obesity83 and intervening in the early postpartum 
period is therefore essential. Several modifiable risk or 
protective factors have been identified, such as infant 
feeding mode (bottle vs breastfeeding), parental respon-
siveness to infant feeding cues and infant distress, the age 
of bottle weaning, timing of the introduction of solid food, 
sweetened beverage consumption and lack of physical 
activity.84–88 Inactivity can delay motor development and 
further increases the risk for early childhood obesity.85 89–91
Parenting skills interventions that focus on these factors 
provide anticipatory guidance and teach parents how to 
identify and respond appropriately to infant cues and 
distress to positively influence self-regulatory capacities, 
well-being and the developing control of the infant’s food 
intake in order to avoid eating in the absence of hunger 
have shown beneficial results.84 85 92 93
theoretical framework for behaviour change interventions
The chosen theoretical framework for the behaviour 
change interventions is the Health Action Process 
Approach (HAPA).94
The HAPA distinguishes between a motivational and a 
volitional phase of behavioural change. In the motivational 
phase, the process of forming an intention to engage in 
a health behaviour takes place. Being aware of a personal 
risk due to the unhealthy behaviour, perceiving more 
benefits than disadvantages of changing the behaviour 
(outcome expectancies) and believing in one’s own abili-
ties to change the behaviour (self-efficacy) are the factors 
that the HAPA specifies to increase the likelihood of a 
behavioural intention to change the behaviour. After an 
intention has been set, the individual enters the volitional 
phase. Here, action control, action planning, coping plan-
ning and again self-efficacy are assumed to be crucial for 
translating the intention into behaviour. Action control 
and its components (ie, the awareness of one’s own stan-
dards for the new behaviour, self-monitoring and regula-
tory effort in case of a discrepancy between the intended 
and the actual behaviour) have been demonstrated in 
several populations and across several behaviours, among 
them physical activity and diet, to be effective in promoting 
behavioural change.95 Moreover, action planning and 
coping planning are crucial postintentional variables in 
the HAPA. Action planning, which is also known as imple-
mentation intentions,96 97 refers to if-then plans regarding 
the exact planning of when, where and how a behaviour 
will be implemented. Implementation intentions have 
been demonstrated to be an effective tool of behavioural 
change in numerous settings and behaviours, displaying 
medium to strong effect sizes.98–100 Coping plans refer 
to plans that specify a critical barrier to the intended/
planned behaviour and a specific strategy on how to cope 
with this barrier.101 A recent systematic review attests that 
the combination of action planning and coping planning 
seems to be most effective for behavioural change.102 
Self-efficacy has also been shown to be a crucial factor in 
health behaviour change across different behaviours and 
different populations.
development of a complex multidimensional interdisciplinary 
lifestyle intervention
Given that single risk factor interventions have shown 
limited efficacy, and considering the multifactorial origins 
of GDM, complex interdisciplinary approaches that start 
in pregnancy and continue postpartum, targeting both 
the mother and the child could be more efficient. This 
is especially important with regard to the intergenera-
tional transmission of risk.103 Some authors specifically 
called for the need to integrate psychological support in a 
lifestyle intervention.104 Typical characteristics of complex 
interventions are that they contain several interacting 
components, their high number of outcomes and that 
a high degree of flexibility or tailoring of the interven-
tion is permitted.105 Furthermore, complex interventions 
work best if tailored to local circumstances rather than 
completely standardised.105
Aims
This study aims to test the effect of an evidence-based, 
complex interdisciplinary lifestyle and psychosocial 
continuous prepartum and postpartum intervention in 
women with GDM on maternal and offspring metabolic 
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and mental health outcomes up to 1 year postpartum. 
It also aims to investigate longitudinal associations, 
thus increasing the understanding of the development 
of maternal and child obesity, glucose intolerance and 
mental health problems.
MEthods
study design
We will conduct a monocentric superiority open 
Randomised Controlled Trial (RCT) with minimal risk 
aiming to test the effect of a multidimensional interdis-
ciplinary lifestyle and psychosocial intervention for preg-
nant women with GDM and their offspring, compared 
with treatment-as-usual (figure 1).
study population, recruitment, group allocation and blinding
Women diagnosed with GDM according to IADPSG 
criteria106 107 will be recruited (1) in our diabetes and 
pregnancy clinic, where patients both from the Univer-
sity Hospital Vaud (CHUV) antenatal care clinic and 
from obstetricians in private practice are referred to 
or (2) referred to our clinic for the study from diabe-
tologists in private practice and from regional hospi-
tals in the canton Vaud. Following their first clinical 
appointment, the study coordinator will explain the 
study and give the information sheet to the patient. 
Participating women will receive for their time, effort 
as well as the fees for their frequent travels CHF 250 
at the 6–8 week postpartum visit and then CHF 200 at 
the 1 year visit.
Figure 1 Trial flowchart.
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The inclusion criteria are as follows: pregnant women 
aged ≥18 years, with GDM at 24–32 weeks of gestation 
and understanding French or English. Women on strict 
bed-rest, with pre-existing DM or current episode of 
severe mental disorder will be excluded.
The allocation ratio of randomisation is 1:1, using the 
block randomisation method (blocks of 4) after stratifica-
tion for the place of the usual care (at the CHUV or the 
respective private diabetologist/regional hospital). Thus, 
each referral centre represents its own control. However, 
all intervention components and all the evaluations take 
place at the CHUV hospital. For allocation of the partici-
pants, a computer-generated list of random blocks is used 
(https://www. sealedenvelope. com/ simple- randomiser). 
The allocation sequence will be concealed from the 
research staff assessing the primary outcomes in sequen-
tially numbered, opaque, sealed envelopes. Envelopes 
will be opened only after the enrolled participants gave 
signed consent and completed all baseline assessments. 
Assessors of primary outcomes and the statistician will be 
blind to group allocation.
Control group
The control group will receive treatment-as-usual, which is 
based on the current guidelines of the American Diabetes 
Association2 and of the Endocrine Society.1 Patients are 
first seen at 24–32 weeks of gestation by a physician and/
or a specialised nurse practitioner who will then provide 
follow-up until childbirth. During the first visit, patients 
learn about GDM and how to perform self-control of 
blood glucose 4 times a day (fasting and 2 hours post-
prandially).1 108
Regarding the weight, lifestyle and mental health goals, 
details are provided in tables 1A and B. Standard advice 
about gestational weight gain according to the Institute of 
Medicine recommendations109 110 will be given. Patients 
have one appointment with a registered dietician in order 
to receive individualised dietary advice, with a focus on 
how to distribute carbohydrate intake over several meals 
and snacks, limit the intake of free sugars to less than 10%, 
and increase fibre intake to up to 30 g per day. Patients 
are encouraged to increase physical activity according 
to the Endocrine Society Guidelines.1 If despite lifestyle 
measures, glucose values remain above targets,1 2 twice 
or more during a 2-week period,108 metformin or insulin 
treatment is installed depending on glucose values (eg, 
insulin in case of relatively high glycaemic values) and 
patient preference.111
In the postpartum period, patients then undergo a 75 g 
oGTT at 6–8 weeks postpartum and are seen afterwards 
by the physician and a dietician jointly to discuss results 
and further management and provide general advice on 
lifestyle measures.1 2 Patients then resume usual care by 
their healthcare provider outside of the clinic.
The frequency of blood glucose self-control, the thresh-
olds for initiating treatment, the choice of the medical 
treatment and the first visit with the dietician will be the 
same in the control and in the intervention group.
Intervention group
The complex, multidimensional, interdisciplinary life-
style and psychosocial intervention will be offered on 
top of usual care. Details for the goals of the interven-
tion group are provided in tables 1A and B. All goals will 
be individually tailored and set by the respective experts 
(dietician and physiotherapist) during the face-to-face 
prepartum consultations, based on the patients’ context 
and capacities112 and transmitted to the coach (see 
below). The goals will also be discussed during bimonthly 
interdisciplinary meetings in the postpartum period and 
exchanges regarding further adaptations.83–86 89–93 113–124
Counselling about gestational weight gain according 
to the Institute of Medicine recommendations and about 
weight retention will be given.109 110 In addition to the 
dietary goals set in the control group, the intervention 
aims to reduce intake of total lipid intake,125 saturated 
fat,126 to prioritise higher quality fats such as monounsat-
urated fat present in the Mediterranean,127 128 DASH and 
plant-based diets and to reduce red or processed meat 
intake.127 It also aims to encourage mindful eating129–131 
and regular, structured eating.1 The intervention also 
includes the promotion of continuous breastfeeding for 
at least 6 months. The intervention encourages aerobic 
and resistance physical activity66 68 132 133 and aims to 
reduce sedentary behaviour.134
Regarding the psychosocial part,135 patients will be 
screened for depression at study beginning, at 6–8 
weeks, at 7 months postpartum and at 1 year postpartum. 
According to a stepped care approach (based on the 
patient’s Edinburgh Postnatal Depression Scale (EPDS) 
score), facilitated self-help with the coach or individual 
cognitive behavioural therapy sessions with the clin-
ical psychologist will be offered.135 Common elements 
are: (1) challenge most unhelpful negative cognitions, 
(2) schedule at least one pleasurable activity per day, 
(3) increase social contacts, (4) improve sleep routine, 
(5) identify most stressful situations and apply cogni-
tive behavioural strategies to improve their manage-
ment.135 136 Patients who require a psychiatric evaluation 
will be referred to a psychiatry liaison service. Treatment 
goals for the offspring focus on diet, breastfeeding, 
nutrition, physical activity137 and emotional regulation, 
all of which will be addressed via psychoeducation and 
parenting training (see tables 1A and B).
The intervention will take place during pregnancy and 
during the first year postpartum and will be delivered 
in individual sessions during the prepartum period with 
members of the multidisciplinary team, in 3–4 monthly 
individual interdisciplinary sessions in the postpartum 
period covering both the mother and the child or during 
group workshops. Throughout the pregnancy and up 
to 1 year postpartum, patients will be accompanied and 
supported by a lifestyle coach (with regular supervision by 
a clinical psychologist) who will monitor adherence to the 
intervention, provide booster messages, identify barriers 
and facilitators, discuss action plans, provide support and 
teach strategies to work towards the individual goals. The 
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coach will offer different behaviour change techniques138 
targeting the HAPA90 constructs relevant for the respec-
tive phase participants are in. Depending on the needs 
and the progress of participants, the content of the theo-
ry-based interventions will be tailored to the individuals. 
Self-monitoring by the patient will help to clarify the situ-
ation and adjust the goals. During pregnancy, the coach 
will have approximately 15 min of biweekly contact (by 
phone, videophone and/or face to face after clinical 
visits). During the first year postpartum, the coach will 
have phone/videophone contact with the mother every 
3 weeks until 6 months and then monthly. Patients will 
receive a folder with written materials and resources and 
worksheets or text messages (according to preferences) 
to monitor their personalised tailored goals and action 
plans in the different domains throughout the study 
period. Close collaboration with paediatricians, obstetri-
cians and existing healthcare networks that form part of 
the patients’ usual clinical care will be ensured.
Social support will be encouraged on three levels.139–141 
First, partners will be invited to attend individual and 
group sessions during both the prepartum and post-
partum period. If partners are unable to attend those 
sessions, a phone/videophone contact at the end of 
the sessions will be offered. Second, small peer support 
groups will be formed during the prepartum and post-
partum workshops. Third, the coach will also transmit 
information about other local support offers and will 
refer the patient to a lactation consultant, if desired by 
the patient. There are no specific other intervention parts D
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Table 1B Goals for the infant up to 1 year (targeted through 
parent education)
Domains Intervention group Control group
Diet Breastfeeding: encourage 
continuation for at least 
6 months184
Soothing: propose alternative 
methods than feeding85 92 121
Hunger and satiety: recognise the 
respective cues92 120
Food: introduce solid food after at 
least 4–6 months of age185
Provide general 
recommendation 
for breastfeeding184
Physical 
activity
Physical activity: encourage 
physical activity during waking 
hours, reaching 180 min/day at 
1 year of age137
Sedentary behaviour: no screen 
time137
No specific 
intervention
Mental 
health
Parental regulation of infant 
distress and self regulation 
capacity: increased through 
parent education during prenatal 
and postnatal workshops and 
postpartum interdisciplinary 
sessions and reinforced by 
coach85 92
No specific 
intervention
BMI, body mass index; EPDS, Edinburgh Postnatal Depression 
Scale; RPE, rate of perceived exertion. 
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for the partners except their integration in the maternal 
and offspring goals, which include a family approach.
Primary outcomes
The primary outcomes are differences between the inter-
vention and the control groups in (1) the decrease in 
maternal weight (calibrated Seca scale) between 24–32 
weeks gestational age (GA) and 1 year postpartum and 
(2) attenuation in maternal symptoms of depression 
(EPDS) during the same time period.
secondary outcomes
Maternal outcomes
The following lifestyle behaviours will be measured: 
carbohydrate and fat intake (Food Frequency Ques-
tionnaire (FFQ), see below), eating behaviour (French 
Intuitive Eating Scale (IES), see below), breastfeeding 
(self-report), physical activity (accelerometer GENE-
Activ), sleep (Pittsburgh Sleep Quality Index (PSQI), see 
below). Aerobic fitness will be estimated using the Chester 
step test (see below) and muscular fitness will be assessed 
with the hand grip strength using a Jamar dynamometer 
(see below). Body composition measures include bioelec-
trical impedance analysis (BIA), the sum of four skin-
folds (Harpenden callipers) as well as Dual-Energy-X-ray 
absorptiometry (iDXA device, GEHC-Lunar, Madison, 
Wisconsin, USA). Cardiometabolic laboratory variables 
and miRNA will be measured (for more details, see Di 
Bernardo et al142).
Additional mental health indicators include anxiety 
(Anxiety subscale of the Hospital Anxiety and Depression 
Scale (HADS), see below), depression (EPDS and Whooley 
questions, see below), well-being (WHO Well-Being 
Index, see below), social support (Medical Outcomes 
Study Social Support Survey-short form (mMOS-SS), see 
below) and parenting stress (Parenting Stress Scale-short 
form (PSI-SF), see below).
Offspring outcomes
Cardiometabolic laboratory variables and miRNA will be 
measured in the cord blood (for more details, see Di 
Bernardo et al142).
 Body composition measures include height, weight (stan-
dardised tools for infants), BIA and the sum of four skin-
folds (Harpenden callipers).
Mental health indicators include self-regulation (Diffi-
cult Child subscale of the Parenting Stress Index-Short 
form, see below) and sleep (Brief Infant Sleep Question-
naire (BISQ), see below).
data collection and visits
The study started in September 2016. The participation 
in the study is voluntary and involves a sequence of events 
and measurements as summarised in table 2.
At 24–32 weeks GA, baseline assessments are carried out 
(visit 1), including the validated questionnaires, physical 
activity and fitness measures, body composition assess-
ments and laboratory variables. If the women agree, their 
partners are also informed about the study and invited 
to participate using a separate information sheet and 
consent form. Once they have signed a separate consent 
form, research staff will measure the partner’s weight 
and height and ask him to complete validated self-report 
questionnaires (table 2).
During childbirth (visit 2), maternal blood will be drawn 
at the entry into the delivery room. After childbirth, blood 
will be drawn from the cord following clamping and 
birth weight will be recorded. Offspring birth weight and 
height will be collected from the hospital birth record.
At 6–8 weeks postpartum (visit 3), while attending a 
clinical appointment, women will be asked to complete a 
series of validated self-report questionnaires online, and 
physical activity and fitness measures, body composition 
assessments and laboratory variables will be measured. 
They will undergo a 75 g oGTT with blood sampling. 
Body composition assessments of their offspring will be 
assessed.
At 1 year postpartum (final visit, visit 4), participants 
will be asked to complete a series of validated self-report 
questionnaires online, and physical activity, aerobic and 
muscular fitness, body composition and laboratory vari-
ables will be measured. Women, who sign an additional 
consent, will also undergo Bone Densitometry (DEXA) 
measures for more detailed body composition. They will 
undergo a 75 g oGTT with blood sampling and blood 
pressure (three measures) will be measured. Body compo-
sition measures of their offspring will again be assessed.
Partners
Partners of participating women who also agree to partic-
ipate will be asked to complete validated questionnaires 
and body composition assessments at study entry and 
study end (when the women are at 24–32 weeks GA and 
at 1 year postpartum, respectively).
Measures
All measures and their timings are listed in detail in 
table 2.
Self-report questionnaires: mother and partner
Symptoms of depression in the preceding 7 days are 
assessed with EPDS,143 which has been validated for preg-
nant women.144 Each item is scored on a 4-point scale, 
the minimum and maximum total scores being 0 and 30, 
respectively. The EPDS has been validated in a French 
sample and good psychometric properties have been 
reported.145 The original authors suggested a cut-off score 
of 12.5 as an indication of clinically significant depression 
but others reported that a score of 10 was the most useful 
cut-off in a French sample of postnatal women.145
Exposure to life events is measured with the Life Events 
Questionnaire (see below), in which participants are given 
a list of three negative pregnancy-related major events 
(suspected growth retardation, vaginal bleeding, prema-
ture contractions) as well as 10 negative pregnancy-unre-
lated major life events (death of someone they were close 
to, serious illness, exposure to abuse, exposure to violence, 
9Horsch A, et al. BMJ Open 2018;8:e020462. doi:10.1136/bmjopen-2017-020462
Open Access
Ta
b
le
 2
 
O
ve
rv
ie
w
 o
f a
ss
es
sm
en
t 
va
ria
b
le
s,
 m
ea
su
re
s 
an
d
 t
im
e 
p
oi
nt
s
D
o
m
ai
n
Va
ri
ab
le
s
M
ea
su
re
s
T
im
in
g
V
is
it
 1
24
–3
2 
G
A
V
is
it
 2
B
ir
th
V
is
it
 3
6–
8 
w
ee
ks
 p
p
V
is
it
 4
1 
ye
ar
 p
p
M
ot
he
r 
 
   P
hy
si
ca
l e
xa
m
in
at
io
n
W
ei
gh
t,
 h
ei
gh
t,
 B
M
I
(p
re
gr
av
id
 w
ei
gh
t 
w
ill
 b
e 
ob
ta
in
ed
 fr
om
 
m
ed
ic
al
 c
ha
rt
s 
an
d
 g
es
ta
tio
na
l w
ei
gh
t 
ga
in
 
an
d
 w
ei
gh
t 
re
te
nt
io
n 
w
ill
 b
e 
ca
lc
ul
at
ed
)
C
al
ib
ra
te
d
 s
ca
le
 (S
ec
a)
, s
ta
nd
ar
d
 s
ta
d
io
m
et
er
X
X
X
To
ta
l f
at
 m
as
s
B
io
im
p
ed
an
ce
, s
ki
nf
ol
d
s 
(c
al
lip
er
s)
X
X
X
To
ta
l a
nd
 r
eg
io
na
l f
at
 m
as
s
D
ua
l-
E
ne
rg
y 
X
-r
ay
 a
b
so
rp
tio
m
et
ry
 (L
un
ar
)—
op
tio
na
l
X
B
lo
od
 p
re
ss
ur
e
O
sc
ill
om
et
ric
 S
p
hy
gm
om
an
om
et
er
X
X
X
 
   S
oc
io
d
em
og
ra
p
hi
c 
b
ac
kg
ro
un
d
S
oc
io
d
em
og
ra
p
hi
c 
va
ria
b
le
s,
 e
xp
os
ur
e 
to
 
lif
e 
ev
en
ts
S
oc
io
d
em
og
ra
p
hi
c 
q
ue
st
io
nn
ai
re
, L
ife
 E
ve
nt
s 
Q
ue
st
io
nn
ai
re
14
6 
14
7
X
X
 
   Li
fe
st
yl
e 
b
eh
av
io
ur
s
C
ar
b
oh
yd
ra
te
 a
nd
 fa
t 
in
ta
ke
Fo
od
 F
re
q
ue
nc
y 
Q
ue
st
io
nn
ai
re
14
8
X
X
E
at
in
g 
b
eh
av
io
ur
Fr
en
ch
 In
tu
iti
ve
 E
at
in
g 
S
ca
le
15
0 
15
1
X
X
B
re
as
tf
ee
d
in
g
S
el
f-
re
p
or
t 
(d
ur
at
io
n 
an
d
 e
xc
lu
si
ve
ne
ss
)
X
X
Fo
od
 t
o 
so
ot
he
Fo
od
 t
o 
S
oo
th
e 
Q
ue
st
io
nn
ai
re
87
X
H
un
ge
r/
sa
tie
ty
 c
lu
es
In
fa
nt
 F
ee
d
in
g 
S
ty
le
 Q
ue
st
io
nn
ai
re
: S
at
ie
ty
 
su
b
sc
al
e1
65
X
P
hy
si
ca
l a
ct
iv
ity
A
cc
el
er
om
et
er
 (G
en
eA
ct
iv
): 
To
ta
l c
ou
nt
s/
m
in
 a
nd
 
tim
e 
sp
en
t 
in
 d
iff
er
en
t 
in
te
ns
iti
es
X
X
 
   Fi
tn
es
s
A
er
ob
ic
 fi
tn
es
s
C
he
st
er
 s
te
p
 t
es
t 
w
ith
 V
O
2m
ax
 e
st
im
at
io
n1
70
X
X
G
rip
 s
tr
en
gt
h
Ja
m
ar
 d
yn
am
om
et
er
17
2
X
X
m
iR
N
A
 (i
n 
p
la
sm
a)
P
la
sm
a;
 v
ar
io
us
 m
iR
N
A
X
X
X
O
ve
ra
ll 
m
et
ab
ol
ic
 c
on
tr
ol
H
b
A
1c
X
X
X
 
   La
b
or
at
or
y 
b
io
m
ar
ke
rs
G
lu
co
se
 t
ol
er
an
ce
75
 g
 o
G
TT
X
X
O
th
er
 c
ar
d
io
m
et
ab
ol
ic
 la
b
or
at
or
y 
b
io
m
ar
ke
rs
G
lu
co
se
, i
ns
ul
in
, H
b
A
1c
, l
ip
id
 p
ro
fil
e,
 in
d
ic
es
 
of
 in
su
lin
 r
es
is
ta
nc
e 
(d
ur
in
g 
oG
TT
)1
86
 a
nd
 o
th
er
 
m
et
ab
ol
ic
 la
b
or
at
or
y 
b
io
m
ar
ke
rs
X
X
X
 
   M
en
ta
l H
ea
lth
D
ep
re
ss
io
n
E
d
in
b
ur
gh
 P
os
tn
at
al
 D
ep
re
ss
io
n 
S
ca
le
14
3
X
X
X
A
nx
ie
ty
A
nx
ie
ty
 s
ub
sc
al
e 
of
 H
os
p
ita
l A
nx
ie
ty
 a
nd
 D
ep
re
ss
io
n 
S
ca
le
15
3
X
X
W
el
l-
b
ei
ng
W
H
O
 W
el
l-
B
ei
ng
 In
d
ex
15
6
X
X
X
P
ar
en
tin
g 
st
re
ss
P
ar
en
tin
g 
S
tr
es
s 
S
ca
le
-s
ho
rt
 fo
rm
18
7
X
X
S
le
ep
 d
ur
at
io
n 
an
d
 q
ua
lit
y
P
itt
sb
ur
gh
 s
le
ep
 q
ua
lit
y 
in
d
ex
16
0
 
   S
oc
ia
l s
up
p
or
t
S
oc
ia
l s
up
p
or
t
M
ed
ic
al
 O
ut
co
m
es
 S
tu
d
y 
S
oc
ia
l S
up
p
or
t 
S
ur
ve
y-
sh
or
t 
fo
rm
16
2
X
X
P
ar
tn
er
 
C
on
tin
ue
d
10 Horsch A, et al. BMJ Open 2018;8:e020462. doi:10.1136/bmjopen-2017-020462
Open Access 
D
o
m
ai
n
Va
ri
ab
le
s
M
ea
su
re
s
T
im
in
g
V
is
it
 1
24
–3
2 
G
A
V
is
it
 2
B
ir
th
V
is
it
 3
6–
8 
w
ee
ks
 p
p
V
is
it
 4
1 
ye
ar
 p
p
 
   P
hy
si
ca
l e
xa
m
in
at
io
n
W
ei
gh
t,
 h
ei
gh
t,
 B
M
I
C
al
ib
ra
te
d
 s
ca
le
 (S
ec
a)
, s
ta
nd
ar
d
 s
ta
d
io
m
et
er
X
X
 
 S
oc
io
d
em
og
ra
p
hi
c 
b
ac
kg
ro
un
d
S
oc
io
d
em
og
ra
p
hi
c 
va
ria
b
le
s,
 e
xp
os
ur
e 
to
 
lif
e 
ev
en
ts
S
oc
io
d
em
og
ra
p
hi
c 
q
ue
st
io
nn
ai
re
, L
ife
 E
ve
nt
s 
Q
ue
st
io
nn
ai
re
14
6 
14
7
X
X
 
 Li
fe
st
yl
e 
b
eh
av
io
ur
s
E
at
in
g 
b
eh
av
io
ur
Fr
en
ch
 In
tu
iti
ve
 E
at
in
g 
S
ca
le
15
0 
15
1
X
X
 
 M
en
ta
l H
ea
lth
D
ep
re
ss
io
n
E
d
in
b
ur
gh
 P
os
tn
at
al
 D
ep
re
ss
io
n 
S
ca
le
14
3
X
X
A
nx
ie
ty
A
nx
ie
ty
 s
ub
sc
al
e 
of
 H
os
p
ita
l A
nx
ie
ty
 a
nd
 D
ep
re
ss
io
n 
S
ca
le
15
3
X
X
W
el
l-
b
ei
ng
W
H
O
 W
el
l-
B
ei
ng
 In
d
ex
15
6
X
X
P
ar
en
tin
g 
st
re
ss
P
ar
en
tin
g 
S
tr
es
s 
S
ca
le
-s
ho
rt
 fo
rm
18
7
X
X
 
 S
oc
ia
l s
up
p
or
t
S
oc
ia
l s
up
p
or
t
M
ed
ic
al
 O
ut
co
m
es
 S
tu
d
y 
S
oc
ia
l S
up
p
or
t 
S
ur
ve
y-
sh
or
t 
fo
rm
16
2
X
X
O
ffs
p
rin
g 
 
 P
hy
si
ca
l e
xa
m
in
at
io
n
W
ei
gh
t,
 h
ei
gh
t,
 B
M
I
C
al
ib
ra
te
d
 b
ab
y 
sc
al
e 
(S
ec
a)
, p
or
ta
b
le
 le
ng
th
 b
oa
rd
X
X
X
To
ta
l f
at
 m
as
s
B
io
im
p
ed
an
ce
X
 
 S
ki
nf
ol
d
s 
(c
al
lip
er
s)
X
X
 
La
b
or
at
or
y 
b
io
m
ar
ke
rs
m
iR
N
A
C
or
d
 b
lo
od
; v
ar
io
us
 m
iR
N
A
X
O
th
er
 c
ar
d
io
m
et
ab
ol
ic
 la
b
or
at
or
y 
b
io
m
ar
ke
rs
C
or
d
 b
lo
od
X
 
M
en
ta
l h
ea
lth
S
el
f-
re
gu
la
tio
n
D
iffi
cu
lt 
C
hi
ld
’ s
ub
sc
al
e 
of
 P
ar
en
tin
g 
S
tr
es
s 
In
d
ex
-
sh
or
t 
fo
rm
18
8
X
S
le
ep
 d
ur
at
io
n 
an
d
 q
ua
lit
y
B
rie
f i
nf
an
t 
sl
ee
p
 q
ue
st
io
nn
ai
re
16
7
X
B
M
I, 
b
od
y 
m
as
s 
in
d
ex
; G
A
, g
es
ta
tio
na
l a
ge
; H
b
A
1c
, g
ly
ca
te
d
 h
ae
m
og
lo
b
in
; o
G
TT
, o
ra
l g
lu
co
se
 t
ol
er
an
ce
 t
es
t;
 P
p
, p
os
tp
ar
tu
m
. 
Ta
b
le
 2
 
C
on
tin
ue
d
 
11Horsch A, et al. BMJ Open 2018;8:e020462. doi:10.1136/bmjopen-2017-020462
Open Access
serious accident, unemployment, disability, alcohol/drug 
abuse, divorce, moving house) and have to indicate whether 
they have been exposed to any of these events in the last 12 
months.146 147
Carbohydrate and fat intake is assessed with the FFQ.148 149 
The FFQ comprises 97 items listing different types of food 
and drinks (tea, butter, tomatoes, chicken and so on) and 
six available spaces which allow the person to write any 
additional food or drinks she/he might have taken over a 
4-week period. Each item is rated for frequency of use on a 
6-point Likert scale ranging from 1 ‘never in the past 4 weeks’ 
to 6 ‘twice a day’. The items are also rated on a quantity 
scale which allows the person to compare the portion they 
took in comparison with a reference portion (ie, 150 g, one 
piece and so on) with three response choices: ‘less’, ‘same’ 
or ‘more’.
Eating behaviour is measured with the French IES,150 151 
assessing an individuals’ tendency to follow their physical 
hunger and satiety cues when determining when, what 
and how much to eat.152 In the current study, the IES was 
modified by taking out the unconditional permission to eat 
scale, as women with GDM are given strict diet counselling. 
Women respond using a 5-point Likert scale ranging from 
1 ‘strongly disagree’ to 5 ‘strongly agree’. To calculate the scale 
scores, negative items are reversed, so that high scores on 
the total measure and subscales indicate greater intuitive 
eating. The individual scores of items under each subscale 
are then summed to obtain subscale scores ranging from 1 
to 5. The French version of the IES-2 demonstrated good 
psychometric properties.151
Anxiety symptoms are assessed with the HADS,153–155 
which has seven items measuring state-anxiety in the last 
7 days. Each item is scored from 0 to 3, with higher scores 
indicating greater anxiety. Scores from 8 to 10 indicate 
possible clinical disorder and scores between 11 and 21 
indicate probable clinical disorder. Furthermore, it may be 
used as a measure of symptom severity from normal (0–7), 
mild (8–10), moderate (11–14), to severe (15–21). The 
HADS has good psychometric properties.154
Well-being is measured with the WHO Well-Being Index 
(WHO-5),156 which consists of 5 questions assessing the 
subjective well-being of the respondents. The items are 
measured on a 5-point Likert scale ranging from 0 ‘at no 
time’ to 5 ‘all of the time’. The scale has adequate validity 
both as a screening tool for depression and as an outcome 
measure in clinical trials and has been applied successfully 
across a wide range of study fields. The scale has been used 
most extensively in endocrinology156 and has good psycho-
metric properties in French.157
Parenting stress is assessed with the PSI-SF.158 It has 36 
items and consists of three subscales that assess parental 
distress, dysfunctional parent–child interactions and 
child difficulties. Items are rated using a 5-point Likert 
scale from 1 ‘totally agree’ to 5 ‘totally disagree’. The PSI has 
good psychometric properties.159
Sleep duration and quality are measured with the PSQI,160 
which has 19 items and measures retrospective sleep quality 
and disturbances over a 1-month period. It discriminates 
between good and poor sleepers and provides a brief, clin-
ically useful assessment of multiple sleep disturbances. The 
19 items are grouped into seven equally weighted compo-
nent scores: Subjective Sleep Quality, Sleep Latency, Sleep 
Duration, Habitual Sleep Efficiency, Sleep Disturbances, 
Use of Sleeping Medication and Daytime Dysfunction. 
Items 1–4 are free entry of: usual bed and wake times, 
minutes of total sleep time and sleep latency (minutes). 
Items 5–18 are rated on a 4-point Likert scale responses 
pertaining to problem frequency: ranging from 0 ‘not 
during the past month’ to 3 ‘three or more times a week’. Item 19 is 
rated on a 4-point Likert scale rating of overall sleep quality 
ranging from 0 ‘very good’ to 3 ‘very bad.’ All component 
scores range from 0 to 3. The Global Score ranges from 0 
to 21, with a higher score indicating poorer sleep quality 
and a cut-off score of >5 distinguishing poor sleepers from 
good sleepers. The questionnaire is validated in French.160 
The English questionnaire was retrieved directly from the 
author.161
Social support is measured with the mMOS-SS,162 which 
has two subscales assessing emotional and instrumental 
social support composed of four items to identify poten-
tially modifiable social support deficits. It has good psycho-
metric properties162 and was translated into French.163
Food to soothe is assessed with the Food to Soothe Ques-
tionnaire,87 the first subscale of the Baby's Basic Needs 
Questionnaire.87 It measures parents’ likeliness to use 
food to soothe their child by 33 items with a Likert scale 
ranging from 1 to 5. Twenty-six items present scenarios 
in which parents might use food to soothe. Seven items 
measure the use of food to encourage/discourage child 
behaviour. Five items are specified as ‘other’ so that the 
parents can fill in specific scenarios that might not be 
addressed in the questionnaire. There are also two more 
questions inviting parents to share more information 
about the use of food to soothe and the use of food to 
encourage or discourage behaviours.87 The scales were 
retrieved by personal communication with the author164 
and translated into French using standard techniques.163
Parental response to hunger/satiety clues is assessed 
with the Infant Feeding Style Questionnaire: Satiety 
subscale,165 designed to assess parental feeding practices. 
This parent-report measure consists of five subscales 
that tap parental control practices and attitudes in child 
feeding.87 In this study, we use the satiety subscale. Two of 
the items probe beliefs and are coded on a 5-point Likert 
scale ranging from 1 ‘disagree’ to 5 ‘agree’. The five other 
items probe behaviours and are coded on a 5-point Likert 
scale ranging from 1 ‘never’ to 5 ‘always’. The scales were 
obtained directly from the author166 and translated into 
French using standard techniques.163
Self-report questionnaires: offspring
Offspring sleep duration and quality are measured with 
the BISQ.167 The role of the responder is asked as 
well as the age, gender and birth order of the child. 
The parent rates their child's nocturnal sleep dura-
tion, daytime sleep duration, number of night waking, 
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duration of wakefulness during the night hours, 
nocturnal sleep-onset time, settling time, method of 
falling asleep, location of sleep and preferred body 
position during the past week. It has 14 items, which 
all have specific scoring measures related to the type 
of question. BISQ scores correlate significantly with 
sleep measures derived from actigraphy and sleep 
diaries.167 The scales were obtained directly from the 
author168 and translated into French using standard 
techniques.163
Offspring self-regulation is assessed with the PSI-SF158 
(see above).
Physical activity and fitness measures
Physical activity (total physical activity and its intensity) 
is assessed using an accelerometer (GeneActiv) that is 
worn on the right wrist during 10 consecutive days.169
The Chester Step Test, a multistage submaximal 
exercise test, is performed to estimate aerobic fitness 
(maximal oxygen uptake (V’O2max)).
170 Before starting 
the test, patients are instructed and experience a 30 s 
familiarisation. During the test, the step rate (assessed 
by an audiotape) starts at 15 step/min and increases 
of 5 step/min every 2 min. Patients are asked to step 
up and down for a maximum of 10 min. Step height 
(15, 20 or 25 cm) can be adapted depending on the 
physical characteristics and/or activity level of the 
patients. Heart rate (HR) and rate of perceived exer-
tion (RPE) on Borg’s scale are monitored at the end 
of each 2 min stage. The test is stopped when patients 
reach 80% of the estimated HRmax (220-age), when 
RPE≥15 or when the patient shows signs of distress 
during the test. The VO2max is then estimated using a 
standardised equation. The Chester step-test was vali-
dated against indirect calorimetry and demonstrated 
reasonable validity.171
Muscular fitness is assessed with a hand grip strength 
dynamometer (Jamar dynamometer) following stan-
dard procedure.172 Before starting the test, patients 
are instructed on the correct use of the dynamom-
eter (hand and wrist position during squeezing). 
Then, patients are seated in a chair and are asked 
to squeeze the dynamometer as tightly as possible. A 
verbal encouragement is given during the test. Three 
measures are taken for each hand and the highest 
value is considered for analysis.
Physical examination: body composition assessments
Weight is measured in mothers, fathers as well as their 
babies to the closest 100 g. For the mothers and fathers, a 
calibrated scale (Seca model 220) is used. Participants are 
asked to remove their shoes as well as any heavy clothing 
(jeans, jacket, scarf and so on). For babies, a calibrated 
scale (model Seca 336) is used and they are weighed 
without any clothes or nappy.
Height is measured in mothers, fathers as well as length 
in babies to the closest mm. For the mothers and fathers, 
a calibrated scale (Seca model 220) is used and they are 
asked to remove their shoes. For babies, a calibrated scale 
(Seca model 336) is used. The infant’s head is placed 
against the head positioner (Seca model 419), then the 
experimenter lightly presses on the infant’s knees and 
measures the infant’s length with the measuring rod 
(Seca model 232).
Total fat mass of the mother and her offspring are 
measured with BIA and skinfolds. BIA measures the 
reactance and the resistance of the patient.173 Any 
metallic objects such as watches, bracelets or others 
are removed before starting the BIA. The participant 
needs to lie down, arms and legs spread away from 
each other, so that there is no contact between the 
limbs. Four electrodes are positioned; two on the 
right hand and two on the right foot, at a distance 
of 3–4 cm from each other (BIA 101, Akern, Italy). 
Obese women with an altered body composition can 
be identified and monitored using vector BIA.174 
A relaxation phase of 10 min is respected before 
measurements are taken. Skinfolds are measured 
with a Harpenden skinfold calliper (HSK-BI, British 
Indicators, UK) on the biceps, the triceps, the 
subscapular and the iliac crest. Muscle tissues are not 
included in the skinfolds. Measures for the mothers 
are taken on the right side of the body while standing 
up. Measurements are taken twice, and a third time 
if the difference between the two first measures is 
over 1 mm. A mean between the two or three values 
is calculated.175 176 For the babies, the measures are 
taken once on the left hand side while their mothers 
are holding them.177
Total and regional fat mass measured by Dual-Energy 
X-ray absorptiometry (mother). Participants are asked 
to remove all metal items before densitometry and are 
examined while wearing only their underwear and a 
cloth gown. The subjects are placed in a supine position 
with their arms at their sides but held slightly separated 
from their trunk and correctly centred on the scanning 
field. Regions of interest are defined by the analytical 
programme, and include different corporeal districts: 
total body, trunk, head, pelvic, upper limbs, lower limbs, 
android and gynoid region. For each region, DXA scans 
bone mineral content, bone areal size and weight (in 
grams) of total mass, FM and non-bone lean mass. For the 
android and gynoid regions, the ratio between android 
and gynoid fat distribution is also assessed. Also calcu-
lated are a FM index (kg/m2), computed as the ratio of 
total body FM over height squared and a skeletal muscle 
mass index (kg/m2), computed as the ratio of appendic-
ular skeletal muscle mass over height squared. Finally, the 
intravisceral fat index is assessed using a special algorithm 
provided by the manufacturer.
Blood pressure in mothers and their partners is measured 
by obtaining three readings at 2 min intervals with a 
clinically validated oscillometric sphygmomanometer 
(OMRON HEM-907, Japan).
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Laboratory variables
Mother
Cardiometabolic laboratory variables such as HbA1c, 
lipid levels, gamma-GT, B12 vitamin, ferritin will be 
measured at study beginning, at 6–8 weeks and at 
1 year postpartum and miRNA will be additionally 
also measured at birth. At 6–8 weeks and at 1 year 
postpartum, a 75 g oGTT with blood sampling at 
30 min intervals for 2 hour will be performed to assess 
glucose tolerance and indices of insulin secretion and 
sensitivity.
Offspring
Cord blood sample will be obtained at the time of 
birth to measure lipid levels, glucose, HbA1c and 
other cardiometabolic laboratory parameters as well 
as miRNA (for more details, see Di Bernardo et al142). 
A sample of the respective blood draw will be kept for 
future potential analyses.
sample size calculation
Sample size was computed based on the expected 
difference in primary outcomes between the control 
and the intervention group. The weight assumptions 
are based on our pilot data and goals for weight reten-
tion. Regarding maternal weight, we assumed a weight 
reduction of 8.4 kg (SD: 5.5) between study enrol-
ment at 24–32 GA, after GDM diagnosis and 1 year 
postpartum in women allocated to the control group 
compared with a weight reduction of 10.9 kg (SD: 5.5) 
in women allocated to the intervention group. The 
required sample size is 76 women in each study group 
to have a statistical significant difference with a power 
of 80% and an alpha-level set at 0.05 (two-sided).
This sample size is also sufficient to observe statis-
tical significant differences in the reduction in the 
Edinburgh Postnatal Depression symptoms score, if 
we assume that the reduction in depression symptoms 
score between the above-mentioned two time points is 
0.2 (SD: 4.3) in women allocated to the control group 
and 2.2 (SD: 4.4) in women allocated to the interven-
tion group. Assuming a maximum attrition rate of 
30%, we will include 100 women in the control and 
100 in the intervention groups to provide adequate 
power.
stAtIstICAL AnALysIs
For the primary aim, differences in the changes in 
maternal weight and the EPDS symptoms score between 
enrolment after GDM diagnosis and 1 year postpartum at 
the end of the study between the intervention and the 
control group will be analysed using linear regression 
analysis. For the secondary aims, the analyses will be 
performed both for differences in changes between the 
intervention and the control group and for differences 
between groups at different time points (baseline at 
inclusion, childbirth, 6–8 weeks and 1 year postpartum) 
in maternal metabolic health outcomes, maternal mental 
health outcomes and offspring metabolic and mental 
health outcomes. This will be tested using linear regres-
sion analysis. We will compare the proportion of patients 
meeting guidelines for gestational weight gain and for 
weight retention at 1 year postpartum between the two 
groups using logistic regression analyses. Associations 
between outcomes will be tested using linear regression 
analyses.
Differences between groups will be adjusted for the 
respective baseline values in case they differ. Vari-
ables will be transformed if residuals are not normally 
distributed. We will include potential confounding 
variables, if necessary. These include maternal age, 
sex of the children, the presence of prenatal, peri-
natal and early postnatal conditions/complications, 
BMI, EPDS symptoms score and socioeconomic 
status where applicable. Subgroup analyses will be 
performed according to weight status, mental health 
status (EPDS score <10 vs ≥10), prediabetes status at 
the initial postpartum evaluation (6–8 weeks post-
partum) as well as sex (for the children). Analyses 
will be conducted with STATA V.14.0. For confirma-
tory analyses, a Bonferroni correction for multiple 
analyses will be applied. For initial exploratory anal-
yses, no such correction will be used.178 For the part-
ners, we will evaluate changes between groups and 
differences between groups at different time points 
(baseline at inclusion, 1 year postpartum) in weight 
and paternal eating behaviour and mental health 
outcomes.
Finally, a process evaluation nested inside the trial will 
be conducted in order to assess fidelity and quality of 
implementation, to clarify causal mechanisms and to 
identify contextual factors associated with variation in 
outcomes.179
AdvErsE EvEnts
All expected and unexpected adverse events will be 
recorded during the entire study period. A recognised 
potential risk is the occurrence of early contractions 
due to intense physical activity. In order to monitor 
and mitigate this potential risk, patients will be closely 
supervised by a physician and a physiotherapist. In case 
of early contractions, participants will be requested to 
reduce or stop their physical activity.
dAtA MAnAGEMEnt
All study data will be entered by research staff (PhD 
students and study co-ordinator). All data will be 
precoded and stored in a secured database (Secutrial), 
which will be regularly updated by the IT Service of the 
Lausanne University Hospital. Double data entry will be 
done for the primary outcomes. For the rest of the data, 
a random 5% will be double-checked.
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MonItorInG
Monitoring will be performed by a qualified person 
independent of the study group and will be organ-
ised in two parts: the initial visit took place before 
the start of recruitment and the second visit after 
approximately 10% of the study population have been 
recruited.
EthICs And dIssEMInAtIon
The trial poses little to no risk to participants and 
their offspring. Signed informed consent is obtained 
from all participating women. Participation in the 
study does not interfere with the typical care patients 
receive during pregnancy and after childbirth. Results 
from this study will be disseminated at regional and 
international conferences and in peer-reviewed jour-
nals. The MySweetHeart Trial is a registered trial ( clin-
icaltrials. gov/ ct2/ show/ NCT02890693) and linked to 
the MySweetHeart Cohort ( clinicaltrials. gov/ ct2/ show/ 
NCT02872974).
sIGnIfICAnCE And outLook
This project will provide relevant findings regarding 
understanding of GDM, potential pathways and its 
link to lifestyle, mental health and the development 
and trajectories of obesity and diabetes in the mothers 
and obesity in their offspring. It will also provide rele-
vant findings regarding treatment of GDM and its 
impact on complications such as diabetes and obesity 
and may thus help to elucidate potential solutions, 
thus leading to significant changes in clinical practice 
and guidelines.
Due to its interdisciplinary nature, this research is 
of interest for clinicians, educators and researchers in 
the field of diabetes, obstetrics, paediatrics and devel-
opment, psychology, sport and nutrition sciences and 
public health.
Author affiliations
1Woman-Mother-Child Department, Lausanne University Hospital, Lausanne, 
Switzerland
2Institute of Higher Education and Research in Healthcare (IUFRS), University of 
Lausanne, Lausanne, Switzerland
3Service of Endocrinology, Diabetes and Metabolism, Lausanne University Hospital, 
Lausanne, Switzerland
4Service of Angiology, Heart and Vessel Department, Lausanne University Hospital, 
Lausanne, Switzerland
5Institute of Sport Sciences, University of Lausanne, Lausanne, Switzerland
6DOHad Laboratory, Pediatrics Division, Woman-Mother-Child Department, 
Lausanne University Hospital, Lausanne, Switzerland
7Center of Bone Diseases, Rheumatology Service, Bone and Joint Department, 
Lausanne University Hospital, Lausanne, Switzerland
8Consultation Liaison Psychiatry, Lausanne University Hospital, Lausanne, 
Switzerland
9Applied Social and Health Psychology, Department of Psychology, University 
Research Priority Program Dynamics of Healthy Aging, University of Zurich, 
Lausanne, Switzerland
10Facultad de Ciencias de la Actividad Física y del Deporte-INEF, Universidad 
Politécnica de Madrid, Madrid, Spain
11Service of Pediatric Endocrinology, Diabetology and Obesity, Lausanne University 
Hospital, Lausanne, Switzerland
Acknowledgements We would like to thank Dominique Stulz, Céline Helbling, 
Véronique Pidoux, Giada Ostinelli, Chloé Beutler and Agnes Bacso for their help 
with administration and data collection. We are grateful to Olivier Le Dizes, Magali 
Andrey, Andrea Orechio, Laura Marino, Antonella Corcillo, Carine Mekoguem, 
Christophe Kosinski, Sylvie Girardin, Stephanie Roudet, for delivering the usual care 
condition and to Nelly Pitteloud and Jean-François Tolsa for departmental support. 
Collaborators The following are members of MySweetHeart Research Group 
(including the authors of the present article), listed in alphabetical order: Ruben 
Barakat, PhD, Professor (Facultad de Ciencias de la Actividad Física y del Deporte-
INEF, Universidad Politécnica de Madrid, Madrid, Spain;  barakatruben@ gmail. 
com), Alexandre Berney, MD, Professor (Consultation Liaison Psychiatry, Lausanne 
University Hospital, Lausanne, Switzerland;  alexander. berney@ chuv. ch), Pascal 
Bovet, MD MPH, Professor (Institute of Social and Preventive Medicine (IUMSP), 
Lausanne University Hospital, Lausanne, Switzerland;  pascal. bovet@ chuv. ch), 
Jenni Brand-Miller, AM, FAIFST, FNSA, Professor (School of Life and Environmental 
Sciences and Charles Perkins Centre, University of Sydney, Australia;  jennie. 
brandmiller@ sydney. edu. au); Arnaud Chiolero, MD PhD, Senior lecturer (Institute of 
Social and Preventive Medicine (IUMSP), Lausanne University Hospital, Lausanne, 
Switzerland; Department of Epidemiology, Biostatistics, and Occupational Health, 
McGill University, Montreal Canada; Institute of Primary Health Care (BIHAM), 
University of Bern, Switzerland;  arnaud. chiolero@ chuv. ch), Stefano Di Bernardo, 
MD, Lecturer (Pediatric Cardiology Unit, Woman-Mother-Child Department, 
Lausanne University Hospital, Lausanne, Switzerland;  stefano. di- bernardo@ chuv. 
ch), Adina Epure, MD (Pediatric Cardiology Unit, Woman-Mother-Child Department; 
Institute of Social and Preventive Medicine (IUMSP), Lausanne University Hospital, 
Lausanne, Switzerland;  adina- mihaela. epure@ chuv. ch), Sandrine Estoppey, M.Sc. 
(Institute of Social and Preventive Medicine (IUMSP), Lausanne University Hospital, 
Lausanne, Switzerland;  sandrine. estoppey@ chuv. ch), Leah Gilbert, M.Sc. (Service 
of Endocrinology, Diabetes and Metabolism, Department of Medicine, Lausanne 
University Hospital, Lausanne, Switzerland;  leah. gilbert@ chuv. ch), Elena Gonzalez-
Rodriguez, MD (Service of Endocrinology, Diabetes and Metabolism, Department of 
Medicine, Lausanne University Hospital, Lausanne, Switzerland;  elena- gonzalez@ 
chuv. ch), Justine Gross, HES (Service of Endocrinology, Diabetes and Metabolism, 
Department of Medicine, Lausanne University Hospital, Lausanne, Switzerland;  
justine. gross@ chuv. ch), Didier Hans, MD (Center of Bone Diseases, Rheumatology 
Service, Bone & Joint Department, Lausanne University Hospital, Lausanne, 
Switzerland;  didier. hans@ chuv. ch), Antje Horsch, DClinPsych, Professor (Institute 
of Higher Education and Research in Healthcare (IUFRS), University of Lausanne 
and Woman-Mother-Child Department, Lausanne University Hospital, Lausanne, 
Switzerland;  antje. horsch@ chuv. ch), Bengt Kayser, MD, PhD, Professor (Institute of 
Sport Sciences, University of Lausanne;  bengt. kayser@ unil. ch), Stefano Lanzi, PhD 
(Service of Endocrinology, Diabetes and Metabolism, Department of Medicine and 
Service of Angiology, Heart and Vessel Department, Lausanne University Hospital, 
Lausanne, Switzerland;  stefano. lanzi@ chuv. ch), Yvan Mivelaz, MD, Lecturer 
(Pediatric Cardiology Unit, Woman-Mother-Child Department, Lausanne University 
Hospital, Lausanne, Switzerland;  yvan. mivelaz@ chuv. ch), Jardena J Puder, MD, 
Professor (Service of Endocrinology, Diabetes and Metabolism, Department 
of Medicine and Service of Pediatric Endocrinology, Diabetology and Obesity, 
Lausanne University Hospital, Lausanne, Switzerland;  jardena. puder@ chuv. ch), Dan 
Quansah, MPH (Service of Endocrinology, Diabetes and Metabolism, Department 
of Medicine, Lausanne University Hospital, Lausanne, Switzerland), Urte Scholz, 
PhD, Professor (Applied Social and Health Psychology, Department of Psychology 
& University Research Priority Program Dynamics of Healthy Aging, University of 
Zurich, Zurich, Switzerland;  urte. scholz@ psychologie. uzh. ch), Nicole Sekarski, MD, 
Professor (Pediatric Cardiology Unit, Woman-Mother-Child Department, Lausanne 
University Hospital, Lausanne, Switzerland;  nicole. sekarski@ chuv. ch), Umberto 
Simeoni, MD, Professor (DOHad Laboratory, Pediatrics Division, Woman-Mother-
Child Department, Lausanne University Hospital, Lausanne, Switzerland;  umberto. 
simeoni@ chuv. ch), Benazir Siddeek, Ph.D. (DOHad Laboratory, Pediatrics Division, 
Woman-Mother-Child Department, Lausanne University Hospital, Lausanne, 
Switzerland;  benazir. siddeek@ chuv. ch), Yvan Vial, MD, Professor (Obstetrics and 
Gynecology Division, Woman-Mother-Child Department, Lausanne University 
Hospital, Lausanne, Switzerland;  yvan. vial@ chuv. ch). 
Contributors JJP and AH designed the study with input from all other authors. AH 
and JJP drafted the manuscript and contributed equally to the present work. LG, SL, 
JG, BK, YV, USi, DH, AB, USc and RB significantly contributed to the establishment 
and refinement of study procedures and critically revised the manuscript. All 
authors approved the final version of the manuscript.
15Horsch A, et al. BMJ Open 2018;8:e020462. doi:10.1136/bmjopen-2017-020462
Open Access
funding This study is funded by a project grant by the Swiss National Science 
Foundation (SNF 32003B_176119).
Competing interests None declared.
Patient consent Obtained.
Ethics approval Ethical approval was granted by the Human Research Ethics 
Committee of the Canton de Vaud (study number 2016-00745). 
Provenance and peer review Not commissioned; peer reviewed for ethical and 
funding approval prior to submission.
data sharing statement Individual participant data collected during the trial (after 
deidentification) that underlie the publications from MySweetHeart research group 
will be available on reasonable request.
open Access This is an Open Access article distributed in accordance with the 
Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which 
permits others to distribute, remix, adapt, build upon this work non-commercially, 
and license their derivative works on different terms, provided the original work is 
properly cited and the use is non-commercial. See: http:// creativecommons. org/ 
licenses/ by- nc/ 4. 0/
© Article author(s) (or their employer(s) unless otherwise stated in the text of the 
article) 2018. All rights reserved. No commercial use is permitted unless otherwise 
expressly granted.
rEfErEnCEs
 1. Blumer I, Hadar E, Hadden DR, et al. Diabetes and pregnancy: 
an endocrine society clinical practice guideline. J Clin Endocrinol 
Metab 2013;98:4227–49.
 2. Association AD. Standards of medical care in diabetes-2017: 
Summary of revisions. Diabetes Care 2017;40:S4–s5.
 3. Benhalima K, Jegers K, Devlieger R, et al. Glucose intolerance after 
a recent history of gestational diabetes based on the 2013 who 
criteria. PLoS One 2016;11:e0157272.
 4. Ryser Rüetschi J, Jornayvaz FR, Rivest R, et al. Fasting 
glycaemia to simplify screening for gestational diabetes. BJOG 
2016;123:2219–22.
 5. Bellamy L, Casas JP, Hingorani AD, et al. Type 2 diabetes mellitus 
after gestational diabetes: a systematic review and meta-analysis. 
Lancet 2009;373:1773–9.
 6. Lauenborg J, Hansen T, Jensen DM, et al. Increasing incidence 
of diabetes after gestational diabetes: a long-term follow-up in a 
Danish population. Diabetes Care 2004;27:1194–9.
 7. Retnakaran R, Shah BR. Mild glucose intolerance in pregnancy and 
risk of cardiovascular disease: a population-based cohort study. 
CMAJ 2009;181:371–6.
 8. Harreiter J, Dovjak G, Kautzky-Willer A. Gestational diabetes 
mellitus and cardiovascular risk after pregnancy. Womens Health 
2014;10:91–108.
 9. Hinkle SN, Buck Louis GM, Rawal S, et al. A longitudinal study 
of depression and gestational diabetes in pregnancy and the 
postpartum period. Diabetologia 2016;59:2594–602.
 10. Nicklas JM, Miller LJ, Zera CA, et al. Factors associated with 
depressive symptoms in the early postpartum period among 
women with recent gestational diabetes mellitus. Matern Child 
Health J 2013;17:1665–72.
 11. Staiano AE, Marker AM, Martin CK, et al. Physical activity, mental 
health, and weight gain in a longitudinal observational cohort of 
nonobese young adults. Obesity 2016;24:1969–75.
 12. Poston L. Maternal obesity, gestational weight gain and diet as 
determinants of offspring long term health. Best Pract Res Clin 
Endocrinol Metab 2012;26:627–39.
 13. Hanson MA, Gluckman PD. Early developmental conditioning of 
later health and disease: physiology or pathophysiology? Physiol 
Rev 2014;94:1027–76.
 14. Simeoni U, Yzydorczyk C, Siddeek B, et al. Epigenetics and 
neonatal nutrition. Early Hum Dev 2014;90 Suppl 2:S23–S24.
 15. Gluckman PD, Hanson MA, Cooper C, et al. Effect of in utero and 
early-life conditions on adult health and disease. N Engl J Med 
2008;359:61–73.
 16. Nehring I, Chmitorz A, Reulen H, et al. Gestational diabetes predicts 
the risk of childhood overweight and abdominal circumference 
independent of maternal obesity. Diabet Med 2013;30:1449–56.
 17. Crume TL, Ogden L, West NA, et al. Association of exposure to 
diabetes in utero with adiposity and fat distribution in a multiethnic 
population of youth: the Exploring Perinatal Outcomes among 
Children (EPOCH) Study. Diabetologia 2011;54:87–92.
 18. Chandler-Laney PC, Bush NC, Granger WM, et al. Overweight 
status and intrauterine exposure to gestational diabetes are 
associated with children's metabolic health. Pediatr Obes 
2012;7:44–52.
 19. Mehta SH, Kruger M, Sokol RJ. Is maternal diabetes a risk factor for 
childhood obesity? J Matern Fetal Neonatal Med 2012;25:41–4.
 20. Pettitt DJ, McKenna S, McLaughlin C, et al. Maternal glucose at 
28 weeks of gestation is not associated with obesity in 2-year-
old offspring: the Belfast Hyperglycemia and Adverse Pregnancy 
Outcome (HAPO) family study. Diabetes Care 2010;33:1219–23.
 21. Zhao P, Liu E, Qiao Y, et al. Maternal gestational diabetes and 
childhood obesity at age 9-11: results of a multinational study. 
Diabetologia 2016;59:2339–48.
 22. Logan KM, Emsley RJ, Jeffries S, et al. Development of early 
adiposity in infants of mothers with gestational diabetes mellitus. 
Diabetes Care 2016;39:1045–51.
 23. Kc K, Shakya S, Zhang H. Gestational diabetes mellitus and 
macrosomia: a literature review. Ann Nutr Metab 2015;66 Suppl 
2:14–20.
 24. Clausen TD, Mathiesen ER, Hansen T, et al. High prevalence of 
type 2 diabetes and pre-diabetes in adult offspring of women 
with gestational diabetes mellitus or type 1 diabetes: the role of 
intrauterine hyperglycemia. Diabetes Care 2008;31:340–6.
 25. Dello Russo M, Ahrens W, De Vriendt T, et al. Gestational 
weight gain and adiposity, fat distribution, metabolic profile, 
and blood pressure in offspring: the IDEFICS project. Int J Obes 
2013;37:914–9.
 26. Black MH, Sacks DA, Xiang AH, et al. The relative contribution of 
prepregnancy overweight and obesity, gestational weight gain, and 
IADPSG-defined gestational diabetes mellitus to fetal overgrowth. 
Diabetes Care 2013;36:56–62.
 27. Harrod CS, Chasan-Taber L, Reynolds RM, et al. Physical activity in 
pregnancy and neonatal body composition: the Healthy Start study. 
Obstet Gynecol 2014;124:257–64.
 28. Lovejoy MC, Graczyk PA, O'Hare E, et al. Maternal depression 
and parenting behavior: a meta-analytic review. Clin Psychol Rev 
2000;20:561–92.
 29. Carter AS, Garrity-Rokous FE, Chazan-Cohen R, et al. Maternal 
depression and comorbidity: predicting early parenting, 
attachment security, and toddler social-emotional problems 
and competencies. J Am Acad Child Adolesc Psychiatry 
2001;40:18–26.
 30. Hoffman C, Crnic KA, Baker JK. Maternal Depression and 
Parenting: Implications for Children's Emergent Emotion Regulation 
and Behavioral Functioning. Parenting 2006;6:271–95.
 31. Wake M, Nicholson JM, Hardy P, et al. Preschooler obesity and 
parenting styles of mothers and fathers: Australian national 
population study. Pediatrics 2007;120:e1520–e1527.
 32. Cosson E, Bihan H, Reach G, et al. Psychosocial deprivation 
in women with gestational diabetes mellitus is associated with 
poor fetomaternal prognoses: an observational study. BMJ Open 
2015;5:e007120.
 33. Ng M, Fleming T, Robinson M, et al. Global, regional, and national 
prevalence of overweight and obesity in children and adults during 
1980-2013: A systematic analysis for the global burden of disease 
study 2013. Lancet 2014;384:766–81.
 34. Hirst JE, Villar J, Papageorghiou AT, et al. Preventing childhood 
obesity starts during pregnancy. Lancet 2015;386:1039–40.
 35. Koivusalo SB, Rönö K, Klemetti MM, et al. Gestational diabetes 
mellitus can be prevented by lifestyle intervention: The finnish 
gestational diabetes prevention study (radiel): A randomized 
controlled trial. Diabetes Care 2016;39:24–30.
 36. Brownfoot FC, Davey MA, Kornman L. Routine weighing to reduce 
excessive antenatal weight gain: a randomised controlled trial. 
BJOG 2016;123:254–61.
 37. Bao W, Bowers K, Tobias DK, et al. Prepregnancy dietary protein 
intake, major dietary protein sources, and the risk of gestational 
diabetes mellitus: a prospective cohort study. Diabetes Care 
2013;36:2001–8.
 38. Garaulet M, Madrid JA. Chronobiological aspects of nutrition, 
metabolic syndrome and obesity. Adv Drug Deliv Rev 
2010;62:967–78.
 39. Pot GK, Almoosawi S, Stephen AM. Meal irregularity and 
cardiometabolic consequences: results from observational and 
intervention studies. Proc Nutr Soc 2016;75:475–86.
 40. Alhussain MH, Macdonald IA, Taylor MA. Irregular meal-pattern 
effects on energy expenditure, metabolism, and appetite regulation: 
a randomized controlled trial in healthy normal-weight women. Am 
J Clin Nutr 2016;104:21–32.
 41. Renault KM, Carlsen EM, Nørgaard K, et al. Intake of sweets, 
snacks and soft drinks predicts weight gain in obese pregnant 
16 Horsch A, et al. BMJ Open 2018;8:e020462. doi:10.1136/bmjopen-2017-020462
Open Access 
women: Detailed analysis of the results of a randomised controlled 
trial. PLoS One 2015;10:e0133041.
 42. Fuglestad PT, Jeffery RW, Sherwood NE. Lifestyle patterns 
associated with diet, physical activity, body mass index and amount 
of recent weight loss in a sample of successful weight losers. Int J 
Behav Nutr Phys Act 2012;9:79.
 43. Hosler AS, Nayak SG, Radigan AM. Stressful events, smoking 
exposure and other maternal risk factors associated with 
gestational diabetes mellitus. Paediatr Perinat Epidemiol 
2011;25:566–74.
 44. Spirito A, Ruggiero L, Bowen A, et al. Stress, coping, and social 
support as mediators of the emotional status of women with 
gestational diabetes. Psychol Health 1991;5:111–20.
 45. Horsch A, Kang JS, Vial Y, et al. Stress exposure and psychological 
stress responses are related to glucose concentrations during 
pregnancy. Br J Health Psychol 2016;21:712–29.
 46. Giesbrecht GF, Campbell T, Letourneau N, et al. Psychological 
distress and salivary cortisol covary within persons during 
pregnancy. Psychoneuroendocrinology 2012;37:270–9.
 47. Sauder KA, Starling AP, Shapiro AL, et al. Diet, physical activity 
and mental health status are associated with dysglycaemia in 
pregnancy: the Healthy Start Study. Diabet Med 2016;33:663–7.
 48. Leppänen M, Aittasalo M, Raitanen J, et al. Physical activity during 
pregnancy: predictors of change, perceived support and barriers 
among women at increased risk of gestational diabetes. Matern 
Child Health J 2014;18:2158–66.
 49. Lydon K, Dunne FP, Owens L, et al. Psychological stress 
associated with diabetes during pregnancy: a pilot study. Ir Med J 
2012;105:26–8.
 50. Perales M, Refoyo I, Coteron J, et al. Exercise during pregnancy 
attenuates prenatal depression: a randomized controlled trial. Eval 
Health Prof 2015;38:59–72.
 51. Huang C, Momma H, Cui Y, et al. Independent and combined 
relationship of habitual unhealthy eating behaviors with 
depressive symptoms: A prospective study. J Epidemiol 
2017;27:42–7.
 52. Mantzios M, Wilson JC. Making concrete construals mindful: a 
novel approach for developing mindfulness and self-compassion to 
assist weight loss. Psychol Health 2014;29:422–41.
 53. Mantzios M, Wilson JC. Exploring mindfulness and mindfulness 
with self-compassion-centered interventions to assist weight loss: 
Theoretical considerations and preliminary results of a randomized 
pilot study. Mindfulness 2015;6:824–35.
 54. Alberts HJ, Mulkens S, Smeets M, et al. Coping with food cravings. 
Investigating the potential of a mindfulness-based intervention. 
Appetite 2010;55:160–3.
 55. Louie JC, Brand-Miller JC, Markovic TP, et al. Glycemic index 
and pregnancy: a systematic literature review. J Nutr Metab 
2010;2010:1–8.
 56. Viana LV, Gross JL, Azevedo MJ. Dietary intervention in patients 
with gestational diabetes mellitus: a systematic review and meta-
analysis of randomized clinical trials on maternal and newborn 
outcomes. Diabetes Care 2014;37:3345–55.
 57. Wei J, Heng W, Gao J. Effects of low glycemic index diets on 
gestational diabetes mellitus: A meta-analysis of randomized 
controlled clinical trials. Medicine 2016;95:e3792.
 58. Han S, Middleton P, Shepherd E, et al. Different types of dietary 
advice for women with gestational diabetes mellitus. Cochrane 
Database Syst Rev 2017;2:Cd009275.
 59. Bowers K, Tobias DK, Yeung E, et al. A prospective study of 
prepregnancy dietary fat intake and risk of gestational diabetes. Am 
J Clin Nutr 2012;95:446–53.
 60. Risérus U, Willett WC, Hu FB. Dietary fats and prevention of type 2 
diabetes. Prog Lipid Res 2009;48:44–51.
 61. Schoenaker DA, Mishra GD, Callaway LK, et al. The role of energy, 
nutrients, foods, and dietary patterns in the development of 
gestational diabetes mellitus: A systematic review of observational 
studies. Diabetes Care 2016;39:16–23.
 62. Bao W, Li S, Chavarro JE, et al. Low carbohydrate-diet scores and 
long-term risk of type 2 diabetes among women with a history of 
gestational diabetes mellitus: A prospective cohort study. Diabetes 
Care 2016;39:43–9.
 63. Hernandez TL, Van Pelt RE, Anderson MA, et al. Women with 
gestational diabetes mellitus randomized to a higher-complex 
carbohydrate/low-fat diet manifest lower adipose tissue insulin 
resistance, inflammation, glucose, and free fatty acids: A pilot study. 
Diabetes Care 2016;39:39–42.
 64. Youngwanichsetha S, Phumdoung S, Ingkathawornwong T. The 
effects of mindfulness eating and yoga exercise on blood sugar 
levels of pregnant women with gestational diabetes mellitus. Appl 
Nurs Res 2014;27:227–30.
 65. Mason AE, Epel ES, Kristeller J, et al. Effects of a mindfulness-
based intervention on mindful eating, sweets consumption, and 
fasting glucose levels in obese adults: data from the SHINE 
randomized controlled trial. J Behav Med 2016;39:201–13.
 66. Anon. ACog committee opinion no. 650: Physical activity and 
exercise during pregnancy and the postpartum period. Obstet 
Gynecol 2015;126:e135–42.
 67. Colberg SR, Sigal RJ, Yardley JE, et al. Physical activity/exercise 
and diabetes: A position statement of the american diabetes 
association. Diabetes Care 2016;39:2065–79.
 68. Colberg SR, Castorino K, Jovanovič L. Prescribing physical activity 
to prevent and manage gestational diabetes. World J Diabetes 
2013;4:256–62.
 69. Melzer K, Schutz Y, Boulvain M, et al. Physical activity and 
pregnancy. Sports Medicine 2010;40:493–507.
 70. Ruchat SM, Mottola MF. The important role of physical activity in 
the prevention and management of gestational diabetes mellitus. 
Diabetes Metab Res Rev 2013;29:334–46.
 71. May LE, Scholtz SA, Suminski R, et al. Aerobic exercise during 
pregnancy influences infant heart rate variability at one month of 
age. Early Hum Dev 2014;90:33–8.
 72. Horsch A, Gross J, Jornayvaz FR, et al. [Gestational diabetes–
what are the non-medical approaches?]. Rev Med Suisse 
2016;12:1089–91.
 73. Brazeau AS, Leong A, Meltzer SJ, et al. Group-based activities with 
on-site childcare and online support improve glucose tolerance 
in women within 5 years of gestational diabetes pregnancy. 
Cardiovasc Diabetol 2014;13:104.
 74. Dasgupta K, Da Costa D, Pillay S, et al. Strategies to optimize 
participation in diabetes prevention programs following gestational 
diabetes: a focus group study. PLoS One 2013;8:e67878.
 75. Brown HL. Acog guidelines at a glance: Gestational diabetes 
mellitus. Obstetrics and gynecology 2013;122:406–16.
 76. Gabbe SG, Landon MB, Warren-Boulton E, et al. Promoting health 
after gestational diabetes: A national diabetes education program 
call to action. Obstet Gynecol 2012;119:171.
 77. Sattar N, Wannamethee SG, Forouhi NG. Novel biochemical risk 
factors for type 2 diabetes: pathogenic insights or prediction 
possibilities? Diabetologia 2008;51:926–40.
 78. Tobias DK, Hu FB, Chavarro J, et al. Healthful dietary patterns 
and type 2 diabetes mellitus risk among women with a history of 
gestational diabetes mellitus. Arch Intern Med 2012;172:1566–72.
 79. Ferrara A, Hedderson MM, Albright CL, et al. A pregnancy and 
postpartum lifestyle intervention in women with gestational diabetes 
mellitus reduces diabetes risk factors: a feasibility randomized 
control trial. Diabetes Care 2011;34:1519–25.
 80. Ferrara A, Hedderson MM, Albright CL, et al. A pragmatic cluster 
randomized clinical trial of diabetes prevention strategies for 
women with gestational diabetes: design and rationale of the 
Gestational Diabetes' Effects on Moms (GEM) study. BMC 
Pregnancy Childbirth 2014;14:21.
 81. Kaiser B, Jeannot E, Razurel C. Determinants of health behaviors 
after gestational diabetes mellitus: A prospective cohort study in 
geneva. J Midwifery Womens Health 2016:571–7.
 82. Koh D, Miller YD, Marshall AL, et al. Health-enhancing physical 
activity behaviour and related factors in postpartum women 
with recent gestational diabetes mellitus. J Sci Med Sport 
2010;13:42–5.
 83. Woo Baidal JA, Locks LM, Cheng ER, et al. Risk factors for 
childhood obesity in the first 1,000 days: A systematic review. Am J 
Prev Med 2016;50:761–79.
 84. Birch LL, Anzman-Frasca S, Paul IM. Starting early: obesity 
prevention during infancy. Nestle Nutr Inst Workshop Ser 
2012;73:81–94.
 85. Paul IM, Bartok CJ, Downs DS, et al. Opportunities for the primary 
prevention of obesity during infancy. Adv Pediatr 2009;56:107–33.
 86. Redsell SA, Edmonds B, Swift JA, et al. Systematic review of 
randomised controlled trials of interventions that aim to reduce the 
risk, either directly or indirectly, of overweight and obesity in infancy 
and early childhood. Matern Child Nutr 2016;12:24–38.
 87. Stifter CA, Anzman-Frasca S, Birch LL, et al. Parent use of food 
to soothe infant/toddler distress and child weight status. An 
exploratory study. Appetite 2011;57:693–9.
 88. Wardle J, Sanderson S, Guthrie CA, et al. Parental feeding style 
and the inter-generational transmission of obesity risk. Obes Res 
2002;10:453–62.
 89. Reilly JJ, Armstrong J, Dorosty AR, et al. Early life risk factors for 
obesity in childhood: cohort study. BMJ 2005;330:1357.
 90. Wen LM, Baur LA, Rissel C, et al. Correlates of body mass index 
and overweight and obesity of children aged 2 years: findings from 
the healthy beginnings trial. Obesity 2014;22:1723–30.
17Horsch A, et al. BMJ Open 2018;8:e020462. doi:10.1136/bmjopen-2017-020462
Open Access
 91. de Vries AG, Huiting HG, van den Heuvel ER, et al. An activity 
stimulation programme during a child's first year reduces some 
indicators of adiposity at the age of two-and-a-half. Acta Paediatr 
2015;104:414–21.
 92. Paul IM, Williams JS, Anzman-Frasca S, et al. The Intervention 
Nurses Start Infants Growing on Healthy Trajectories (INSIGHT) 
study. BMC Pediatr 2014;14:184.
 93. French GM, Nicholson L, Skybo T, et al. An evaluation of mother-
centered anticipatory guidance to reduce obesogenic infant feeding 
behaviors. Pediatrics 2012;130:e507–517.
 94. Schwarzer R. Modeling Health Behavior Change: How to Predict 
and Modify the Adoption and Maintenance of Health Behaviors. 
Appl Psychol 2008;57:1–29.
 95. Berli C, Stadler G, Inauen J, et al. Action control in dyads: A 
randomized controlled trial to promote physical activity in everyday 
life. Soc Sci Med 2016;163:89–97.
 96. Leventhal H, Singer R, Jones S. EFFECTS OF FEAR AND 
SPECIFICITY OF RECOMMENDATION UPON ATTITUDES AND 
BEHAVIOR. J Pers Soc Psychol 1965;2:20–9.
 97. Gollwitzer PM. Implementation intentions: Strong effects of simple 
plans. Am Psychol 1999;54:493–503.
 98. Gollwitzer PM, Sheeran P. Implementation intentions and goal 
achievement: A meta‐analysis of effects and processes. Adv Exp 
Soc Psychol 2006;38:69–119.
 99. Hagger MS, Luszczynska A. Implementation intention and action 
planning interventions in health contexts: state of the research and 
proposals for the way forward. Appl Psychol Health Well Being 
2014;6:1–47.
 100. Hagger MS, Luszczynska A, de Wit J, et al. Implementation 
intention and planning interventions in Health Psychology: 
Recommendations from the Synergy Expert Group for research and 
practice. Psychol Health 2016;31:814–39.
 101. Sniehotta FF, Scholz U, Schwarzer R. Action plans and coping 
plans for physical exercise: A longitudinal intervention study in 
cardiac rehabilitation. Br J Health Psychol 2006;11:23–37.
 102. Kwasnicka D, Presseau J, White M, et al. Does planning how to 
cope with anticipated barriers facilitate health-related behaviour 
change? A systematic review. Health Psychol Rev 2013;7:129–45.
 103. Seshiah V, Balaji V. Primordial prevention: maternal health and 
diabetes. Diabetes Manag 2013;3:333–41.
 104. Halperin IJ, Feig DS. The role of lifestyle interventions in the 
prevention of gestational diabetes. Curr Diab Rep 2014;14:452.
 105. Craig P, Dieppe P, Macintyre S, et al. Developing and evaluating 
complex interventions: the new Medical Research Council 
guidance. Int J Nurs Stud 2013;50:587–92.
 106. Metzger BE, Gabbe SG, Persson B, et al. International Association 
of Diabetes and Pregnancy Study Groups Recommendations on 
the Diagnosis and Classification of Hyperglycemia in Pregnancy: 
Response to Weinert. Diabetes Care 2010;33:e98–82.
 107. Nolan CJ. Controversies in gestational diabetes. Best Pract Res Clin 
Obstet Gynaecol 2011;25:37–49.
 108. Crowther CA, Hiller JE, Moss JR, et al. Effect of treatment of 
gestational diabetes mellitus on pregnancy outcomes. N Engl J 
Med 2005;352:2477–86.
 109. Sox HC, Greenfield S. Comparative effectiveness research: a report 
from the Institute of Medicine. Ann Intern Med 2009;151:203–5.
 110. Yaktine AL, Rasmussen KM. Weight gain during pregnancy: 
reexamining the guidelines. Washington (DC): National Academies 
Press, 2009.
 111. Carroll DG, Kelley KW. Review of metformin and glyburide in the 
management of gestational diabetes. Pharm Pract 2014;12:528.
 112. Ferrer RL, Carrasco AV. Capability and clinical success. Ann Fam 
Med 2010;8:454–60.
 113. Daniels LA, Mallan KM, Nicholson JM, et al. Outcomes of an 
early feeding practices intervention to prevent childhood obesity. 
Pediatrics 2013;132:e109–118.
 114. Farrow C, Blissett J. Does maternal control during feeding 
moderate early infant weight gain? Pediatrics 2006;118:e293–e298.
 115. Gunderson EP, Hurston SR, Ning X, et al. Lactation and Progression 
to Type 2 Diabetes Mellitus After Gestational Diabetes Mellitus: A 
Prospective Cohort Study. Ann Intern Med 2015;163:889–98.
 116. Herring SJ, Rich-Edwards JW, Oken E, et al. Association of 
postpartum depression with weight retention 1 year after childbirth. 
Obesity 2008;16:1296–301.
 117. Hori H, Teraishi T, Sasayama D, et al. Relationship of temperament 
and character with cortisol reactivity to the combined 
dexamethasone/CRH test in depressed outpatients. J Affect Disord 
2013;147:128–36.
 118. Iglowstein I, Jenni OG, Molinari L, et al. Sleep duration from 
infancy to adolescence: reference values and generational trends. 
Pediatrics 2003;111:302–7.
 119. Mallan KM, Daniels LA, Wilson JL, et al. Association between 
maternal depressive symptoms in the early post-natal period and 
responsiveness in feeding at child age 2 years. Matern Child Nutr 
2015;11:926–35.
 120. Mallan KM, Sullivan SE, de Jersey SJ, et al. The relationship 
between maternal feeding beliefs and practices and perceptions of 
infant eating behaviours at 4 months. Appetite 2016;105:1–7.
 121. Paul IM, Savage JS, Anzman SL, et al. Preventing obesity during 
infancy: a pilot study. Obesity 2011;19:353–61.
 122. Redsell SA, Weng S, Swift JA, et al. Validation, Optimal Threshold 
Determination, and Clinical Utility of the Infant Risk of Overweight 
Checklist for Early Prevention of Child Overweight. Child Obes 
2016;12:202–9.
 123. Taveras EM, Blackburn K, Gillman MW, et al. First steps for mommy 
and me: a pilot intervention to improve nutrition and physical 
activity behaviors of postpartum mothers and their infants. Matern 
Child Health J 2011;15:1217–27.
 124. Zarrinpar A, Chaix A, Panda S. Daily Eating Patterns and 
Their Impact on Health and Disease. Trends Endocrinol Metab 
2016;27:69–83.
 125. SSN. Swiss Society for Nutrition. Nutritional recommendations for 
Germany, Autria and Switzerland (DACH): Les valeurs de référence 
DACH pour les apports nutritionnels. 2ème édn, 2015.
 126. Ansermet O, Aebi A. Influence des protéines et des lipides chez le 
diabétique de type 1. Genève, Switzerland: Haute école de santé, 
2016.
 127. Ley SH, Hamdy O, Mohan V, et al. Prevention and management 
of type 2 diabetes: dietary components and nutritional strategies. 
Lancet 2014;383:1999–2007.
 128. Marathe PH, Gao HX, Close KL. American Diabetes Association 
Standards of Medical Care in Diabetes 2017. J Diabetes 
2017;9:320–4.
 129. Mantzios M, Wilson JC. Mindfulness, Eating Behaviours, and 
Obesity: A Review and Reflection on Current Findings. Curr Obes 
Rep 2015;4:141–6.
 130. Mathieu J. What should you know about mindful and intuitive 
eating? J Am Diet Assoc 2009;109:1982–7.
 131. Medina WL, Wilson D, de Salvo V, et al. Effects of Mindfulness 
on Diabetes Mellitus: Rationale and Overview. Curr Diabetes Rev 
2017;13:141–7.
 132. Barakat R, Lucia A, Ruiz JR. Resistance exercise training during 
pregnancy and newborn's birth size: a randomised controlled trial. 
Int J Obes 2009;33:1048–57.
 133. Organization WH. Global strategy on diet, physical activity and 
health: WHO, 2017.
 134. Healy GN, Dunstan DW, Salmon J, et al. Breaks in sedentary 
time: beneficial associations with metabolic risk. Diabetes Care 
2008;31:661–6.
 135. Excellence NIfHaC. Antenatal and postnatal mental health: clinical 
management and service guidance. London: National Institute for 
Health and Care Excellence, 2014.
 136. Sockol LE. A systematic review of the efficacy of cognitive 
behavioral therapy for treating and preventing perinatal depression. 
J Affect Disord 2015;177:7–21.
 137. Tremblay MS, Leblanc AG, Carson V, et al. Canadian Physical 
Activity Guidelines for the Early Years (aged 0-4 years). Appl Physiol 
Nutr Metab 2012;37:345–56.
 138. Michie S, Richardson M, Johnston M, et al. The behavior change 
technique taxonomy (v1) of 93 hierarchically clustered techniques: 
building an international consensus for the reporting of behavior 
change interventions. Ann Behav Med 2013;46:81–95.
 139. Da Costa D, Dritsa M, Larouche J, et al. Psychosocial predictors of 
labor/delivery complications and infant birth weight: a prospective 
multivariate study. J Psychosom Obstet Gynaecol 2000;21:137–48.
 140. Devsam BU, Bogossian FE, Peacock AS. An interpretive review of 
women's experiences of gestational diabetes mellitus: proposing 
a framework to enhance midwifery assessment. Women Birth 
2013;26:e69–e76.
 141. Wadhwa PD, Entringer S, Buss C, et al. The contribution of 
maternal stress to preterm birth: issues and considerations. Clin 
Perinatol 2011;38:351–84.
 142. S db, M Y, E A, et al. Assessing the consequences of gestational 
diabetes mellitus on offspring’s cardiovascular health: 
MySweetHeart Cohort study protocol, Switzerland. BMJ Open in 
press 2017;7:e016972.
 143. Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression. 
Development of the 10-item Edinburgh Postnatal Depression Scale. 
Br J Psychiatry 1987;150:782–6.
 144. Bunevicius A, Kusminskas L, Pop VJ, et al. Screening for antenatal 
depression with the Edinburgh Depression Scale. J Psychosom 
Obstet Gynaecol 2009;30:238–43.
18 Horsch A, et al. BMJ Open 2018;8:e020462. doi:10.1136/bmjopen-2017-020462
Open Access 
 145. Guedeney N, Fermanian J. Validation study of the French version 
of the Edinburgh Postnatal Depression Scale (EPDS): new 
results about use and psychometric properties. Eur Psychiatry 
1998;13:83–9.
 146. Koch FS, Sepa A, Ludvigsson J. Psychological stress and obesity. J 
Pediatr 2008;153:839–44.
 147. Obel C, Hedegaard M, Henriksen TB, et al. Stress and 
salivary cortisol during pregnancy. Psychoneuroendocrinology 
2005;30:647–56.
 148. Jean-Marc T. Plan de codage des variables: questionnaires activité 
physique (PAFQ) et alimentaires (FFQ), 2009.
 149. Theler. Food frequency questionnaire. Switzerland, 2016.
 150. Daundasekara SS, Beasley AD, O'Connor DP, et al. Validation 
of the intuitive Eating Scale for pregnant women. Appetite 
2017;112:201–9.
 151. Camilleri GM, Méjean C, Bellisle F, et al. Cross-cultural validity of 
the Intuitive Eating Scale-2. Psychometric evaluation in a sample of 
the general French population. Appetite 2015;84:34–42.
 152. Tylka TL, Kroon Van Diest AM. The Intuitive Eating Scale-2: item 
refinement and psychometric evaluation with college women and 
men. J Couns Psychol 2013;60:137–53.
 153. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. 
Acta Psychiatr Scand 1983;67:361–70.
 154. Bocéréan C, Dupret E. A validation study of the Hospital Anxiety 
and Depression Scale (HADS) in a large sample of French 
employees. BMC Psychiatry 2014;14:1.
 155. Herrmann C, Buss U, Snaith R. Hospital Anxiety and Depression 
Scale–Deutsche Version [Ein Fragebogen von Angst und 
Depressivität in der somatischen Medizin]. Bern, Schweiz: Hans 
Huber, 1995.
 156. Topp CW, Østergaard SD, Søndergaard S, et al. The WHO-5 
Well-Being Index: a systematic review of the literature. Psychother 
Psychosom 2015;84:167–76.
 157. Hochberg G, Pucheu S, Kleinebreil L, et al. WHO-5, a tool focusing 
on psychological needs in patients with diabetes: the French 
contribution to the DAWN study. Diabetes Metab 2012;38:515–22.
 158. Abidin R, Index PS. Parenting Stress Index (PSI). Odessa, FL: 
Psychological Assessment Resources:Inc, 1995.
 159. Singer LT, Salvator A, Guo S, et al. Maternal psychological distress 
and parenting stress after the birth of a very low-birth-weight infant. 
JAMA 1999;281:799–805.
 160. Smith MT, Wegener ST. Measures of sleep: The Insomnia Severity 
Index, Medical Outcomes Study (MOS) Sleep Scale, Pittsburgh 
Sleep Diary (PSD), and Pittsburgh Sleep Quality Index (PSQI). 
Arthritis & Rheumatism 2003;49:S184–196.
 161. Raphael H. Pittsburgh sleep quality index, 2016.
 162. Moser A, Stuck AE, Silliman RA, et al. The eight-item modified 
Medical Outcomes Study Social Support Survey: psychometric 
evaluation showed excellent performance. J Clin Epidemiol 
2012;65:1107–16.
 163. Wild D, Grove A, Martin M, et al. Principles of Good Practice for the 
Translation and Cultural Adaptation Process for Patient-Reported 
Outcomes (PRO) Measures: report of the ISPOR Task Force for 
Translation and Cultural Adaptation. Value Health 2005;8:94–104.
 164. Stifter C. Food to soothe questionnaire, 2016.
 165. Thompson AL, Mendez MA, Borja JB, et al. Development and 
validation of the Infant Feeding Style Questionnaire. Appetite 
2009;53:210–21.
 166. Thompson A. Infant feeding style questionnaire: satiety subscale, 
2016.
 167. Sadeh A. A brief screening questionnaire for infant sleep 
problems: validation and findings for an Internet sample. Pediatrics 
2004;113:e570–e577.
 168. Sadeh A. Brief infant sleep questionnaire. 2016.
 169. Esliger DW, Rowlands AV, Hurst TL, et al. Validation of the GENEA 
Accelerometer. Med Sci Sports Exerc 2011;43:1085–93.
 170. Sykes K, Roberts A. The Chester step test—a simple yet 
effective tool for the prediction of aerobic capacity. Physiotherapy 
2004;90:183–8.
 171. Melzer K, Lazzeri M, Armand S, et al. Validation of the Actiheart 
for estimating physical activity related energy expenditure in 
pregnancy. Espen J 2012;7:e5–e10.
 172. Roberts HC, Denison HJ, Martin HJ, et al. A review of the 
measurement of grip strength in clinical and epidemiological 
studies: towards a standardised approach. Age Ageing 
2011;40:423–9.
 173. Bertrand PC. Marche à suivre pour la mesure de la composition 
corpoirelle par BIA (Body impedance analyser RJL systems-
AKERN). Lausanne, Suisse: CCHU, 2008.
 174. Guida B, Trio R, Pecoraro P, et al. Impedance vector distribution 
by body mass index and conventional bioelectrical impedance 
analysis in obese women. Nutr Metab Cardiovasc Dis 
2003;13:72–9.
 175. Knonthropometry ISftao. International standards for anthropometric 
assessment: International Society for the advancement of 
Knonthropometry.
 176. Durnin JV, Womersley J. Body fat assessed from total body 
density and its estimation from skinfold thickness: measurements 
on 481 men and women aged from 16 to 72 years. Br J Nutr 
1974;32:77–97.
 177. Dauncey MJ, Gandy G, Gairdner D. Assessment of total body fat 
in infancy from skinfold thickness measurements. Arch Dis Child 
1977;52:223–7.
 178. Rothman KJ. No adjustments are needed for multiple comparisons. 
Epidemiology 1990;1:43–6.
 179. Oakley A, Strange V, Bonell C, et al. Process evaluation in 
randomised controlled trials of complex interventions. BMJ 
2006;332:413–6.
 180. Ferrara A, Hedderson MM, Brown SD, et al. The comparative 
effectiveness of diabetes prevention strategies to reduce 
postpartum weight retention in women with gestational diabetes 
mellitus: The Gestational Diabetes’ Effects on Moms (GEM) cluster 
randomized controlled trial. Diabetes Care 2016;39:65–74.
 181. Nishida C. Guideline: sugars intake for adults and children, 2016.
 182. Les hydrates de carbone dans l'alimentation: résumés des 
chapitres. Les hydrates de carbone dans l'alimentation. Berne, 
Switzerland: Federal Office of Public Health Fsd, 2009.
 183. Montonen J, Knekt P, Järvinen R, et al. Whole-grain and fiber 
intake and the incidence of type 2 diabetes. Am J Clin Nutr 
2003;77:622–9.
 184. Lake AC M. Breastfeeding: a key to sustainable development. 
World breastfeeding week Message 2016: Organization UWH, 2016.
 185. Swiss Society for Nutrition Nutritional recommendations. 
L'alimentation du nourrisson durant la première année de vie. 
Berne: Swiss Society for Nutrition Nutritional recommendations, 
2012.
 186. Phillips DI, Clark PM, Hales CN, et al. Understanding oral glucose 
tolerance: comparison of glucose or insulin measurements during 
the oral glucose tolerance test with specific measurements 
of insulin resistance and insulin secretion. Diabet Med 
1994;11:286–92.
 187. Berry JO, Jones WH. The parental stress scale: initial psychometric 
evidence. J Soc Pers Relat 1995;12:463–72.
 188. Abidin RR, Brunner JF. Development of a parenting alliance 
inventory. J Clin Child Psychol 1995;24:31–40.
